http://www.pharmajournalist.com/insilico-announces-a-multi-target-ai-powered-drug-discovery-collaboration-with-janssen/ 2020-11-13T14:37:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/ultragenyx-announces-plans-to-build-large-scale-gene-therapy-manufacturing-facility-to-support-pipeline-of-therapies-for-rare-diseases/ 2020-11-13T14:50:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Ultragenyxlogo.gif http://www.pharmajournalist.com/vifor-pharma-and-angion-sign-license-agreement-for-ang-3777-in-nephrology-indications/ 2020-11-13T14:53:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Vifor-Pharma-Logo.jpg http://www.pharmajournalist.com/calquence-approved-in-the-eu-for-the-treatment-of-chronic-lymphocytic-leukaemia/ 2020-11-13T14:55:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/sagent-pharmaceuticals-launches-phase-2-trial-to-evaluate-camostat-mesilate-for-covid-19-treatment/ 2020-11-13T14:58:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Sagent-Pharma-Logo.png http://www.pharmajournalist.com/tezepelumab-navigator-trial-in-severe-uncontrolled-asthma-patients-meets-primary-endpoint/ 2020-11-13T15:00:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/forma-therapeutics-announces-ft-4202-receives-orphan-drug-designation-in-europe-for-treatment-of-sickle-cell-disease/ 2020-11-13T15:02:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forma_Logo.jpg http://www.pharmajournalist.com/viiv-healthcare-announces-investigational-injectable-cabotegravir-is-superior-to-oral-standard-of-care-for-hiv-prevention-in-women/ 2020-11-13T15:03:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/ViiV-Healthcare.png http://www.pharmajournalist.com/eli-lilly-gets-fda-eua-status-for-bamlanivimab-to-treat-covid-19/ 2020-11-13T15:05:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/sedor-pharmaceuticals-receives-fda-approval-for-sesquient-to-treat-status-epilepticus/ 2020-11-13T15:07:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pharmaron-acquires-absorption-systems-in-the-usa/ 2020-11-13T15:09:17+00:00 https://pharmajournalist.com/wp-content/uploads/2016/09/pharmaron.png http://www.pharmajournalist.com/cphi-p-mec-china-2020-adapts-to-customer-needs-with-hybrid-pharma-event/ 2020-11-17T03:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/CPhI-P-MEC-China-Virtual-Expo-Connect-300x250-NEW.jpg http://www.pharmajournalist.com/panel-discussion-on-covid-19-how-has-the-rna-industry-adapted-to-beat-the-pandemic/ 2020-11-16T12:49:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/RNA-2021.jpg http://www.pharmajournalist.com/gene-therapy-for-blood-disorders-biomarin-insights-fda-ema-guidelines-demonstrating-durability-and-more/ 2020-11-18T09:43:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Gene-Therapy-for-Blood-Disorders.png http://www.pharmajournalist.com/1-week-to-go-webinar-on-cost-efficient-and-green-manufacturing-of-peptides-thanks-to-molecular-hiving-technology/ 2020-11-20T09:29:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/1200x627-Speaker.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/11/1200x627-Speaker.jpg http://www.pharmajournalist.com/baricitinib-receives-emergency-use-authorization-from-the-fda-for-the-treatment-of-hospitalized-patients-with-covid-19/ 2020-11-20T15:03:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/imfinzi-approved-in-the-us-for-less-frequent-fixed-dose-use/ 2020-11-20T15:05:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/jj-initiates-second-global-phase-3-clinical-trial-of-its-janssen-covid-19-vaccine-candidate/ 2020-11-20T15:06:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/samsung-bioepis-and-biogen-announce-fda-filing-acceptance-of-sb11-a-proposed-biosimilar-referencing-lucentis-ranibizumab/ 2020-11-20T15:08:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/pfizer-and-biontech-conclude-phase-3-study-of-covid-19-vaccine-candidate-meeting-all-primary-efficacy-endpoints/ 2020-11-20T15:10:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/bristol-myers-squibb-completes-acquisition-of-myokardia/ 2020-11-20T15:13:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/redhill-biopharma-initiates-phase-3-study-of-rhb-204-for-first-line-treatment-of-ntm-disease/ 2020-11-20T15:21:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo.png http://www.pharmajournalist.com/lead-pharma-enters-into-a-research-collaboration-and-license-agreement-with-roche-to-develop-oral-small-molecules-for-immune-mediated-diseases/ 2020-11-20T15:24:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Lead-Pharma-Logo.jpg http://www.pharmajournalist.com/zymeworks-receives-orphan-drug-designation-from-the-european-commission-for-her2-targeted-bispecific-antibody-zanidatamab-in-patients-with-gastric-cancer/ 2020-11-20T15:28:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Zymeworks.jpg http://www.pharmajournalist.com/novartis-secures-exclusive-rights-for-potential-acute-respiratory-distress-syndrome-cell-therapy/ 2020-11-20T15:31:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/rilzabrutinib-granted-fda-fast-track-designation-for-treatment-of-immune-thrombocytopenia/ 2020-11-20T15:33:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/cerebral-therapeutics-announces-enrollment-of-first-patient-in-a-multicenter-randomized-controlled-phase-2b-trial-in-epilepsy/ 2020-11-20T15:35:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Cerebral-Therapeutics-Logo.png http://www.pharmajournalist.com/ema-begins-rolling-review-of-modernas-mrna-vaccine-candidate-against-covid-19-mrna-1273/ 2020-11-20T15:38:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/moderna-announces-supply-agreement-with-united-kingdom-government-to-supply-mrna-vaccine-against-covid-19-mrna-1273-if-approved-for-use/ 2020-11-20T15:41:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/viiv-healthcare-receives-fda-breakthrough-therapy-designation-for-investigational-long-acting-cabotegravir-for-hiv-prevention/ 2020-11-20T15:44:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/ViiV-Healthcare.png http://www.pharmajournalist.com/merck-advances-phase-3-trial-to-evaluate-investigational-islatravir-as-once-monthly-oral-prep-for-women-at-high-risk-for-acquiring-hiv-1/ 2020-11-20T15:52:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/olema-oncology-announces-clinical-trial-agreement-to-evaluate-op-1250-in-combination-with-palbociclib-ibrance-in-advanced-metastatic-breast-cancer/ 2020-11-20T15:54:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/olema-oncology.png http://www.pharmajournalist.com/aeterna-zentaris-amends-license-agreement-with-novo-nordisk-for-commercialization-and-development-of-macimorelin/ 2020-11-20T15:57:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Aeterna-Zentaris.png http://www.pharmajournalist.com/assembly-biosciences-and-door-pharmaceuticals-sign-collaboration-and-option-agreement-to-develop-a-novel-class-of-hbv-core-protein-modulators/ 2020-11-20T16:00:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/assemblybio.jpg http://www.pharmajournalist.com/inmed-pharmaceuticals-and-baymedica-announce-collaboration-for-manufacturing-and-testing-of-novel-cannabinoid-therapeutics/ 2020-11-20T16:02:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Inmed-Pharma-Logo.png http://www.pharmajournalist.com/exclusive-interview-with-julia-frese-tuv-sud-released-ahead-of-pre-filled-syringes-europe/ 2020-11-23T10:55:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/PFS-UPDATED.jpg http://www.pharmajournalist.com/registration-is-now-open-for-pre-filled-syringes-east-coast-virtual-conference-2021/ 2020-11-25T09:48:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/chairs-post-an-invitation-letter-for-the-15th-annual-parallel-trade-conference-2021/ 2020-11-26T09:44:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/bioinvent-and-cantargia-sign-manufacturing-agreement-for-monoclonal-antibody-can10/ 2020-11-27T12:34:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/altimmune-announces-submission-of-investigational-nda-for-adcovid/ 2020-11-27T12:38:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/altimmune_logo.png http://www.pharmajournalist.com/biontech-and-instadeep-announce-strategic-collaboration-and-form-ai-innovation-lab-to-develop-novel-immunotherapies/ 2020-11-27T12:40:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/biontech-and-fosun-pharma-announce-the-start-of-a-phase-2-clinical-trial-of-lead-mrna-covid-19-vaccine-bnt162b2-in-china/ 2020-11-27T12:42:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/BioNTech.jpg http://www.pharmajournalist.com/roche-announces-fda-approval-of-xofluza-for-the-prevention-of-influenza-following-contact-with-an-infected-person/ 2020-11-27T12:44:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/moderna-announces-the-european-commissions-approval-of-advance-purchase-agreement-for-initial-80-million-doses-of-mrna-vaccine-against-covid-19-mrna-1273/ 2020-11-27T12:46:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/hifibio-therapeutics-inks-partnership-with-pharmsynthez-and-ibch-for-the-clinical-development-and-commercialization-of-its-sars-cov-2-neutralizing-antibody-in-russia/ 2020-11-27T12:48:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/merck-to-acquire-oncoimmune/ 2020-11-27T12:50:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/quadramune-synergizes-with-metformin-to-stimulate-anti-viral-defenses-in-pilot-clinical-trial/ 2020-11-27T13:15:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/oncosec-announces-exclusive-license-agreement-for-cliniporator-gene-electrotransfer-platform-developed-by-igea-clinical-biophysics/ 2020-11-27T13:17:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/OncoSec.jpg http://www.pharmajournalist.com/redhill-biopharma-expands-u-s-based-manufacturing-capacity-of-opaganib-for-covid-19/ 2020-11-27T13:19:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo.png http://www.pharmajournalist.com/biogen-and-sage-therapeutics-announce-global-collaboration-to-develop-and-commercialize-potential-breakthrough-therapies-in-depression-and-movement-disorders/ 2020-11-27T13:20:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/ema-validates-application-for-tepotinib-for-the-treatment-of-advanced-nsclc-with-metex14-skipping-alterations/ 2020-11-27T13:23:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/haoma-medica-completes-first-in-human-trial-for-naquinate-a-novel-treatment-in-development-for-osteoporosis/ 2020-11-27T13:25:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/astellas-receives-approval-of-evrenzo-roxadustat-in-japan-for-the-treatment-of-anemia-of-chronic-kidney-disease-in-adult-patients-not-on-dialysis/ 2020-11-27T13:28:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/celltrion-completes-enrolment-for-global-phase-ii-clinical-trial-with-covid-19-treatment-candidate-ct-p59/ 2020-11-27T13:30:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/fda-defers-approval-of-daxibotulinumtoxina-for-injection-in-glabellar-lines-due-to-covid-19-related-travel-restrictions-impacting-manufacturing-site-inspection/ 2020-11-27T13:32:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/apnimed-announces-first-patient-dosed-in-phase-2-clinical-trial-with-ad109-lead-candidate-for-treatment-of-obstructive-sleep-apnea/ 2020-11-27T13:41:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Untitled.png http://www.pharmajournalist.com/gsk-starts-phase-3-study-of-rsv-maternal-candidate-vaccine/ 2020-11-27T13:43:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/pfizer-doses-first-participant-in-phase-3-study-evaluating-anti-tfpi-investigational-therapy-marstacimab-for-people-with-severe-hemophilia-a-and-b-with-or-without-inhibitors/ 2020-11-27T13:44:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/curevac-and-wacker-sign-manufacturing-contract-for-curevacs-covid-19-vaccine-candidate-cvncov/ 2020-11-27T13:49:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Curevac-logo.png http://www.pharmajournalist.com/lonza-and-be-the-match-biotherapies-partner-to-expand-vein-to-vein-cell-and-gene-therapy-supply-chain-network/ 2020-11-27T13:50:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/syngene-and-deerfield-discovery-and-development-3dc-sign-5-year-strategic-collaboration/ 2020-11-27T13:52:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Syngene.jpg http://www.pharmajournalist.com/boston-scientific-receives-fda-approval-for-wavewriter-alpha-spinal-cord-stimulator-systems/ 2020-12-04T13:13:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Boston-scientific-logo.png http://www.pharmajournalist.com/bayer-and-atara-biotherapeutics-enter-strategic-collaboration-for-mesothelin-targeted-car-t-cell-therapies-for-solid-tumors/ 2020-12-07T12:13:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/y-mabs-and-takeda-announce-exclusive-license-and-distribution-agreement-for-danyelza-naxitamab-gqgk-and-omburtamab-in-israel/ 2020-12-07T12:15:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/tevard-biosciences-and-zogenix-announce-collaboration-to-advance-novel-gene-therapies-for-dravet-syndrome-and-other-genetic-epilepsies/ 2020-12-07T12:19:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Tevard-Biosciences-Logo.jpg http://www.pharmajournalist.com/exclusive-interview-with-severine-duband-nemera-released-ahead-of-pre-filled-syringes-europe/ 2020-12-07T12:19:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/PFS-UPDATED.jpg http://www.pharmajournalist.com/merck-and-artios-pharma-announce-a-global-strategic-collaboration-on-novel-dna-damage-response-targets-in-oncology/ 2020-12-07T12:21:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/tubulis-forms-strategic-partnership-with-wuxi-biologics-and-wuxi-sta-to-advance-new-generation-of-antibody-drug-conjugates-towards-clinical-evaluation/ 2020-12-07T12:22:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/exelixis-in-licenses-iconic-therapeutics-tissue-factor-targeting-antibody-drug-conjugate-ahead-of-planned-investigational-new-drug-application/ 2020-12-07T12:25:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/cho-plus-announces-research-collaboration-agreement-with-janssen/ 2020-12-07T12:27:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/CHO-Plus.jpg http://www.pharmajournalist.com/atbtherapeutics-initiates-agreement-with-ibio-cdmo-to-manufacture-game-changer-atbodies-to-better-treat-cancer/ 2020-12-07T12:30:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/ATB_Antibody.jpg http://www.pharmajournalist.com/cedilla-and-hitgen-announce-research-collaboration-focused-on-dna-encoded-library-based-drug-discovery/ 2020-12-07T12:33:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Hitgen-Logo.jpg http://www.pharmajournalist.com/telix-pharmaceuticals-limited-acquires-therapharm-gmbh-broadening-reach-to-hematologic-cancers-and-transplant-medicine/ 2020-12-07T12:34:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/moderna-announces-amendment-to-current-supply-agreement-with-united-kingdom-government-for-an-additional-2-million-doses-of-mrna-vaccine-against-covid-19-mrna-1273/ 2020-12-07T12:36:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/biogen-and-sage-therapeutics-announce-global-collaboration-to-develop-and-commercialize-potential-breakthrough-therapies-in-depression-and-movement-disorders-2/ 2020-12-30T18:29:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/syros-acquires-clinical-stage-drug-candidate-for-acute-promyelocytic-leukemia-expanding-its-pipeline-of-targeted-therapies-for-hematologic-malignancies/ 2020-12-07T12:40:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Syros-Logo.png http://www.pharmajournalist.com/neurogene-announces-ema-grants-orphan-drug-designation-for-aspartylglucosaminuria-gene-therapy/ 2020-12-07T12:47:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Neurogene-Logo.png http://www.pharmajournalist.com/janssen-acquires-rights-to-novel-gene-therapy-pioneering-treatment-solutions-for-late-stage-age-related-macular-degeneration/ 2020-12-07T12:49:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/fda-approves-xolair-omalizumab-for-adults-with-nasal-polyps/ 2020-12-07T12:50:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/roche-receives-fda-emergency-use-authorization-for-new-test-to-measure-the-level-of-sars-cov-2-antibodies/ 2020-12-07T12:52:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/roche-announces-fda-approval-of-gavreto-pralsetinib-for-people-with-advanced-or-metastatic-ret-mutant-and-ret-fusion-positive-thyroid-cancers/ 2020-12-07T12:54:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/first-patient-dosed-in-appili-therapeutics-phase-3-clinical-trial-of-avigan-tablets-favipiravir-for-the-treatment-of-covid-19-in-the-united-states/ 2020-12-07T12:56:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/APPILI_Logo.jpg http://www.pharmajournalist.com/lilly-announces-650000-additional-doses-of-neutralizing-antibody-bamlanivimab-ly-cov555-purchased-by-u-s-government-to-treat-covid-19/ 2020-12-07T12:58:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/dr-reddys-and-rdif-commence-clinical-trials-for-sputnik-v-vaccine-in-india/ 2020-12-07T12:59:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/zymeworks-announces-expansion-of-zanidatamab-pivotal-trial-in-her2-amplified-biliary-tract-cancer-in-asia-in-collaboration-with-beigene/ 2020-12-07T13:02:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Zymeworks.jpg http://www.pharmajournalist.com/smi-group-invite-microbiologists-to-4th-annual-pharmaceutical-microbiology-east-coast-virtual-conference/ 2020-12-08T13:12:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/P-345-Brochure-Image-only.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/12/P-345-Brochure-Image-only.jpg http://www.pharmajournalist.com/exclusive-interview-with-dr-eric-noehrenberg-president-nipc-released-ahead-of-parallel-trade-conference-2021/ 2020-12-08T13:24:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/rna-therapeutics-conference-brings-together-industry-experts-and-holistic-view-on-the-latest-developments/ 2020-12-08T13:32:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/RNA-2021.jpg http://www.pharmajournalist.com/pfizer-and-biontech-receive-fda-advisory-committee-vote-supporting-potential-first-emergency-use-authorization-for-vaccine-to-combat-covid-19-in-the-u-s/ 2020-12-11T09:49:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/arcus-biosciences-expands-strategic-relationship-with-wuxi-biologics-to-develop-antibody-for-the-treatment-of-cancer/ 2020-12-11T09:52:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Arcus-Biosciences-logo.png http://www.pharmajournalist.com/boehringer-ingelheim-to-acquire-labor-dr-merk-kollegen-to-strengthen-its-next-generation-cancer-immunology-program/ 2020-12-11T09:54:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/inovio-and-advaccine-announce-first-dosing-of-subject-in-phase-2-clinical-trial-for-covid-19-dna-vaccine-candidate-ino-4800-in-china/ 2020-12-11T10:01:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/lilly-and-unitedhealth-group-partner-on-pragmatic-study-of-neutralizing-antibody-bamlanivimab-ly-cov555-for-covid-19/ 2020-12-11T10:03:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/sinovac-announces-product-license-for-23-valent-pneumococcal-polysaccharide-vaccine/ 2020-12-11T10:07:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Sinovac-Biotech-Logo.jpg http://www.pharmajournalist.com/boehringer-ingelheim-to-acquire-nbe-therapeutics/ 2020-12-11T10:09:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/inveniai-and-kyowa-kirin-enter-ai-powered-novel-target-discovery-collaboration/ 2020-12-11T10:22:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Inveni-AI-logo.png http://www.pharmajournalist.com/applied-biomath-llc-announces-collaboration-with-antengene-for-systems-pharmacology-modeling-in-oncology/ 2020-12-11T10:24:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/applied-biomath-logo.png http://www.pharmajournalist.com/intec-pharma-announces-cannabinoid-research-collaboration-with-gw-pharma/ 2020-12-11T10:27:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Intec-Pharma-Logo.png http://www.pharmajournalist.com/aligos-enters-into-an-exclusive-license-and-research-collaboration-agreement-with-merck-to-discover-and-develop-an-oligonucleotide-therapy-for-nash/ 2020-12-11T10:30:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/ALIGOS-Therapeutics-Logo.png http://www.pharmajournalist.com/postera-enters-a-multi-year-strategic-partnership-with-pfizer-to-advance-machine-learning-for-drug-discovery/ 2020-12-11T10:32:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Post-Era-Logo.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-further-expands-global-footprint-for-drug-product-development-and-commercial-manufacturing/ 2020-12-11T10:47:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-in-metastatic-breast-cancer/ 2020-12-11T10:49:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/amgens-sotorasib-granted-breakthrough-therapy-designation-for-advanced-or-metastatic-non-small-cell-lung-cancer-patients-with-kras-g12c-mutation/ 2020-12-11T10:52:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/cybin-signs-definitive-agreement-to-acquire-adelia-therapeutics-as-part-of-its-commitment-to-strategic-growth/ 2020-12-11T11:03:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/cybin-logo.jpg http://www.pharmajournalist.com/pfizer-sangamo-announce-updated-results-of-phase-1-2-alta-study-of-giroctocogene-fitelparvovec/ 2020-12-11T11:06:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/passage-bio-teams-with-catalent-to-start-cgmp-manufacturing-for-lead-gene-therapy-products/ 2020-12-11T11:10:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Passage-Bio-Logo.jpeg http://www.pharmajournalist.com/recipharm-invests-usd-2-5-million-in-clinical-gmp-capacity-for-active-pharmaceutical-ingredients/ 2020-12-11T11:13:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/exclusive-interview-julian-bahr-postdoctoral-fellow-at-astrazeneca-and-speaker-at-3d-cell-culture-conference/ 2020-12-17T11:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/P-340-1200x627-Julian-Bahr-VIRTUAL.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/12/P-340-1200x627-Julian-Bahr-VIRTUAL.jpg http://www.pharmajournalist.com/conference-chair-from-johnson-johnson-invites-you-to-attend-pre-filled-syringes-east-coast-2021/ 2020-12-17T11:25:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300-x-250.jpg http://www.pharmajournalist.com/investigational-covid-19-therapeutics-to-be-evaluated-in-large-clinical-trials/ 2020-12-18T13:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/20201217-covid.jpg https://pharmajournalist.com/wp-content/uploads/2020/12/20201217-covid.jpg http://www.pharmajournalist.com/novartis-builds-on-commitment-to-addressing-need-in-neuropsychiatric-disorders-with-cadent-therapeutics-acquisition/ 2020-12-18T13:17:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-investigational-oral-therapy-iptacopan-lnp023-receives-fda-breakthrough-therapy-designation-for-pnh-and-rare-pediatric-disease-designation-for-c3g/ 2020-12-18T13:19:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-announces-positive-fda-advisory-committee-recommendation-for-use-of-entresto-to-treat-patients-with-hfpef/ 2020-12-18T13:21:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-reports-positive-topline-results-from-second-phase-iii-trial-of-beovu-in-patients-with-diabetic-macular-edema/ 2020-12-18T13:22:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/biontech-and-fosun-pharma-to-supply-china-with-mrna-based-covid-19-vaccine/ 2020-12-18T13:24:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/pfizer-and-biontech-provide-data-from-german-phase-1-2-study-further-characterizing-immune-response-following-immunization-with-lead-covid-19-vaccine-candidate-bnt162b2/ 2020-12-18T13:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/lilly-announces-agreement-to-acquire-prevail-therapeutics/ 2020-12-18T13:27:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/gavi-the-vaccine-alliance-collaborates-with-salesforce-to-help-equitably-distribute-two-billion-covid-19-vaccines-by-the-end-of-2021/ 2020-12-18T13:30:12+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Salesforce-Logo.png http://www.pharmajournalist.com/moderna-receives-fda-advisory-committee-vote-supporting-emergency-use-for-modernas-vaccine-against-covid-19-in-the-united-states/ 2020-12-18T13:31:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/eureka-therapeutics-announces-successful-preclinical-results-of-invisimask-human-antibody-nasal-spray-against-sars-cov-2-infection/ 2020-12-18T13:34:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/invisimask-eureka.jpg https://pharmajournalist.com/wp-content/uploads/2020/12/invisimask-eureka.jpg http://www.pharmajournalist.com/astrazeneca-to-acquire-alexion-accelerating-the-companys-strategic-and-financial-development/ 2020-12-18T13:47:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/sonoma-and-crown-laboratories-announce-an-exclusive-partnership-to-launch-microcyn-technology-based-anti-itch-over-the-counter-products/ 2020-12-18T13:51:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Sonoma-Pharma-Logo.jpg http://www.pharmajournalist.com/teon-therapeutics-announces-approval-for-collaboration-with-cancer-research-uk/ 2020-12-18T13:53:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/Teon-Therapeutics-Logo.png http://www.pharmajournalist.com/ashvattha-therapeutics-announces-collaboration-with-stanford-university-for-preclinical-development-of-a-novel-neuroimaging-agent-op-801/ 2020-12-18T13:56:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/vtv-therapeutics-announces-licensing-agreement-for-novel-nrf2-activator-to-anteris-bio/ 2020-12-18T13:57:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/adc-therapeutics-and-overland-pharma-form-strategic-jv-to-expand-adc-drugs-development-and-commercialization-in-greater-china-and-singapore-advised-by-msq-ventures/ 2020-12-18T13:59:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/ADC_Therapeutics_Logo.png http://www.pharmajournalist.com/genosity-enters-into-an-agreement-with-gemini-therapeutics-to-develop-a-diagnostic-and-implement-testing-to-support-geminis-age-related-macular-degeneration-trial/ 2020-12-18T14:00:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ultragenyx-and-mereo-biopharma-announce-collaboration-and-license-agreement-for-setrusumab-in-osteogenesis-imperfecta/ 2020-12-18T14:02:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Ultragenyxlogo.gif http://www.pharmajournalist.com/fda-approves-gsks-benlysta-as-the-first-medicine-for-adult-patients-with-active-lupus-nephritis-in-the-us/ 2020-12-18T14:04:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/fsd-pharma-announces-first-patient-randomized-in-phase-2-trial-of-fsd201-for-the-treatment-of-hospitalized-patients-with-covid-19/ 2020-12-18T14:07:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/FSD-Logo.jpg http://www.pharmajournalist.com/acceleron-receives-orphan-designation-from-the-european-commission-ec-for-sotatercept-in-pulmonary-arterial-hypertension-pah/ 2020-12-18T14:08:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/logo-acceleron.png http://www.pharmajournalist.com/exclusive-interview-with-mark-depristo-bighat-bioscience-speaker-at-ai-in-drug-discovery-2021/ 2020-12-23T09:03:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/P-343-AI-in-Drug-Discovery-Virtual-Conference-300x250-1.jpg http://www.pharmajournalist.com/key-presentations-not-to-be-missed-at-pre-filled-syringes-europe/ 2021-01-04T12:00:27+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/PFS-UPDATED.jpg http://www.pharmajournalist.com/stefan-przyborski-from-university-of-durham-invites-you-to-join-3d-cell-culture-virtual-conference/ 2021-01-05T08:20:21+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/P-340-1200x627-Chair-Stefan-Przyborski-Virtual.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/01/P-340-1200x627-Chair-Stefan-Przyborski-Virtual.jpg http://www.pharmajournalist.com/hear-from-leading-pharmaceutical-biotech-companies-and-regulatory-experts-at-rna-therapeutics-2021/ 2021-01-07T13:25:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/RNA-2021.jpg http://www.pharmajournalist.com/merck-acquires-amptec-to-expand-mrna-capabilities-for-vaccines-treatments-and-diagnostics/ 2021-01-11T10:49:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/am-pharma-announces-enrollment-and-financing-of-covid-19-cohort-in-phase-iii-revival-trial/ 2021-01-11T10:51:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/curevac-and-bayer-join-forces-on-covid-19-vaccine-candidate-cvncov/ 2021-01-11T10:52:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/bluerock-therapeutics-in-collaboration-with-memorial-sloan-kettering-cancer-center-receives-ind-clearance-for-da01-in-parkinsons-disease/ 2021-01-11T10:54:40+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/BlueRock-Therapeutics.jpg http://www.pharmajournalist.com/lifearc-funds-covid-19-drug-screening-hub-at-the-university-of-glasgow/ 2021-01-11T10:57:49+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/University-of-Glasgow.jpg http://www.pharmajournalist.com/akston-biosciences-and-lakepharma-announce-strategic-partnership-to-manufacture-second-generation-covid-19-vaccine/ 2021-01-11T10:59:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/israeli-ministry-of-health-authorizes-covid-19-vaccine-moderna-for-use-in-israel/ 2021-01-11T11:02:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/atyr-pharma-announces-positive-topline-results-from-phase-2-clinical-trial-of-atyr1923-in-covid-19-patients-with-severe-respiratory-complications/ 2021-01-11T11:04:41+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/atyr-logo.png http://www.pharmajournalist.com/post-conference-masterclass-in-eu-distribution-strategy-implementation-at-parallel-trade-2021/ 2021-01-11T11:06:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/pfizer-doses-first-participant-in-phase-3-study-for-duchenne-muscular-dystrophy-investigational-gene-therapy/ 2021-01-11T11:07:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/celularity-and-gx-acquisition-corp-announce-merger-agreement-to-create-a-publicly-listed-leader-in-allogeneic-cellular-therapy/ 2021-01-11T11:09:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Celularity-Inc-Headquarters.jpg http://www.pharmajournalist.com/innovations-in-parenteral-delivery-connectivity-and-regulatory-guidance-at-pre-filled-syringes-east-coast-2021/ 2021-01-11T11:10:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300-x-250.jpg http://www.pharmajournalist.com/affinivax-announces-226-million-series-c-financing-to-advance-its-pipeline-of-novel-maps-vaccines-targeting-infectious-diseases/ 2021-01-11T11:11:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/teva-and-medincell-announce-positive-results-for-registration-trial-of-investigational-extended-release-subcutaneous-injectable-risperidone-for-patients-with-schizophrenia/ 2021-01-11T11:14:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/xencor-and-md-anderson-enter-strategic-collaboration-to-develop-novel-t-cell-engaging-bispecific-antibodies-for-potential-treatment-of-patients-with-cancer/ 2021-01-11T11:16:10+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation-for-ntm-disease/ 2021-01-11T11:17:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo.png http://www.pharmajournalist.com/incyte-and-cellenkos-enter-into-global-development-collaboration-agreement-for-ck0804/ 2021-01-11T11:20:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/insilico-enters-into-a-collaboration-with-aprinoia-to-apply-novel-generative-ai-powered-system-to-discover-novel-compounds-for-neurodegenerative-diseases/ 2021-01-11T11:40:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/immunitybio-simulates-sars-cov-2-spike-protein-binding-using-molecular-dynamics/ 2021-01-11T11:42:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunityBio-Logo.png http://www.pharmajournalist.com/agc-biologics-confirms-cell-and-gene-therapy-commercial-expertise-as-manufacturer-of-orchard-therapeutics-newly-approved-libmeldy/ 2021-01-11T11:43:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AGC-Biologics.jpg http://www.pharmajournalist.com/angelini-pharma-acquires-arvelle-therapeutics-to-create-a-leading-european-innovator-in-central-nervous-system-cns-and-mental-health-disorder-treatments/ 2021-01-11T11:46:35+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Angelini-Pharma-Logo.jpg http://www.pharmajournalist.com/morphic-expands-research-and-development-collaboration-with-janssen-through-third-integrin-program/ 2021-01-11T11:48:48+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Morphic-Therapeutics-Logo.jpg http://www.pharmajournalist.com/almirall-and-tyris-therapeutics-enter-into-strategic-partnership-to-develop-next-generation-gene-therapies/ 2021-01-11T11:50:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Almirall_Plant_Reinbek.jpg http://www.pharmajournalist.com/imaginab-announces-license-and-supply-agreement-with-pfizer-for-cd8-immunopet-technology/ 2021-01-11T11:51:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImaginAb-Logo.jpg http://www.pharmajournalist.com/dewpoint-announces-collaboration-with-pfizer-to-develop-potential-therapies-for-a-rare-form-of-muscular-dystrophy/ 2021-01-11T11:54:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/dewpoint-logo.jpg http://www.pharmajournalist.com/darren-green-gsk-conference-chair-invitation-to-attend-ai-in-drug-discovery-virtual-conference/ 2021-01-12T09:26:01+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/P-343-Brochure-with-Darren-Green-Chair-only.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/01/P-343-Brochure-with-Darren-Green-Chair-only.jpg http://www.pharmajournalist.com/boehringer-ingelheim-and-enara-bio-enter-strategic-collaboration-and-licensing-agreement-to-discover-novel-shared-antigens-for-cancer-immunotherapies/ 2021-01-15T09:56:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/fda-accepts-for-priority-review-the-biologics-license-application-for-v114-mercks-investigational-15-valent-pneumococcal-conjugate-vaccine-for-use-in-adults-18-years-of-age-and-older/ 2021-01-15T09:58:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/swissmedic-authorizes-covid-19-vaccine-moderna-for-use-in-switzerland/ 2021-01-15T10:02:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/sanofi-to-acquire-kymab-adding-ky1005-to-its-pipeline-a-human-monoclonal-antibody-targeting-key-immune-system-regulator-ox40l/ 2021-01-15T10:08:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/humanigen-and-eversana-announce-partnership-to-support-the-launch-and-commercialization-of-lenzilumab-for-the-treatment-of-covid-19/ 2021-01-15T10:18:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Humanigen_Logo.jpg http://www.pharmajournalist.com/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-for-patients-with-chronic-spontaneous-urticaria-csu/ 2021-01-15T10:22:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/ksq-therapeutics-and-takeda-enter-broad-strategic-collaboration-to-research-develop-and-commercialize-novel-immuno-oncology-therapies/ 2021-01-15T10:24:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/bayer-announces-u-s-fda-accepts-new-drug-application-and-grants-priority-review-for-investigational-drug-finerenone-for-patients-with-chronic-kidney-disease-and-type-2-diabetes/ 2021-01-15T10:25:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/amneal-to-acquire-substantially-all-of-kashiv-specialty-pharmaceuticals/ 2021-01-15T10:27:10+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Amneal-Pharma.jpg http://www.pharmajournalist.com/vir-biotechnology-and-gsk-announce-nhs-supported-agile-study-to-evaluate-vir-7832-in-the-early-treatment-of-covid-19/ 2021-01-15T10:29:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/rocket-pharmaceuticals-announces-buildout-of-rd-and-manufacturing-facility-to-support-development-of-innovative-gene-therapy-pipeline/ 2021-01-15T10:32:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Rocket-Pharmaceuticals-Headquarters.jpg http://www.pharmajournalist.com/beigene-announces-collaboration-with-novartis-to-develop-and-commercialize-anti-pd-1-antibody-tislelizumab/ 2021-01-15T11:44:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Beigene.jpg http://www.pharmajournalist.com/gsk-mmv-filing-for-kozenis-tafenoquine-in-paediatric-populations-with-plasmodium-vivax-malaria-accepted-by-australian-therapeutic-goods-administration/ 2021-01-15T11:46:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/nucleai-and-debiopharm-launch-research-collaboration-utilizing-nucleais-ai-powered-biomarker-platform/ 2021-01-15T11:48:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/angelini-pharma-acquires-arvelle-therapeutics-to-create-a-leading-european-innovator-in-central-nervous-system-cns-and-mental-health-disorder-treatments-2/ 2021-01-15T11:51:57+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Angelini-Pharma-Logo.jpg http://www.pharmajournalist.com/gilead-and-vir-biotechnology-establish-clinical-collaboration-to-explore-combination-strategies-for-functional-cure-for-chronic-hepatitis-b-virus/ 2021-01-15T11:54:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/sosei-heptares-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery-against-challenging-gpcr-target/ 2021-01-15T11:55:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/avantgen-announces-licensing-of-its-anti-sars-cov-2-antibodies-to-igm-biosciences-for-covid-19-therapy-development/ 2021-01-15T11:57:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/AvantGen-Logo.jpg http://www.pharmajournalist.com/registration-opens-for-smis-3rd-annual-injectable-drug-delivery-conference/ 2021-01-20T09:16:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/300x250.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/06/300x250.jpg http://www.pharmajournalist.com/six-key-microbiology-presentations-from-fda-steris-boehringer-ingelheim-microbiological-consulting-parexel/ 2021-01-22T10:07:32+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/P-345-300x300-with-strap-virtual.jpg http://www.pharmajournalist.com/turn-therapeutics-receives-authorization-to-commence-human-trial-for-covid-19-therapeutic-candidate/ 2021-01-22T10:25:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/akron-biotech-signs-exclusive-global-agreement-with-octapharma-to-produce-virally-inactivated-human-ab-serum-derived-from-octaplas-for-the-cell-therapy-market/ 2021-01-22T10:31:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Akron-Biotech-Logo.jpg http://www.pharmajournalist.com/lilly-and-merus-nv-announce-collaboration-to-discover-novel-t-cell-re-directing-bispecific-antibodies/ 2021-01-22T10:34:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/syntegra-partnering-with-national-institutes-of-health-nih-and-the-bill-and-melinda-gates-foundation-to-democratize-access-to-the-largest-set-of-covid-19-patient-records/ 2021-01-22T10:35:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/aruvant-chooses-lonza-to-manufacture-aru-1801-a-potentially-curative-treatment-for-sickle-cell-disease-for-pivotal-trial/ 2021-01-22T10:37:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-acquires-viral-vector-manufacturing-business-from-novasep/ 2021-01-22T10:39:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-to-acquire-point-of-care-molecular-diagnostics-provider-mesa-biotech/ 2021-01-22T10:40:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/servier-and-mina-therapeutics-enter-collaboration-in-neurological-diseases/ 2021-01-22T10:43:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png http://www.pharmajournalist.com/cure-genetics-collaborates-with-boehringer-ingelheim-to-develop-novel-aav-vectors-enabling-the-next-generation-liver-targeted-gene-therapy/ 2021-01-22T10:45:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/tennor-enters-research-collaboration-with-janssen-for-potential-new-treatments-for-nontuberculous-mycobacteria-diseases/ 2021-01-22T10:46:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/cocrystal-pharma-announces-further-development-of-influenza-a-b-antiviral-compounds-by-merck-under-exclusive-worldwide-license-and-collaboration-agreement/ 2021-01-22T10:50:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Cocrystal-Pharma-Logo.png http://www.pharmajournalist.com/t-cure-bioscience-and-immunotech-biopharm-ltd-announce-license-agreement-for-novel-herv-e-t-cell-receptor-therapy/ 2021-01-22T10:53:00+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/T-Cure-Logo.png http://www.pharmajournalist.com/nexelis-acquires-the-gsk-vaccines-clinical-bioanalytical-laboratory-located-in-marburg-germany-and-enters-into-a-5-year-strategic-agreement-with-gsk/ 2021-01-22T10:54:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Nexelis-Logo.jpg http://www.pharmajournalist.com/mitsubishi-tanabe-pharma-america-and-aquestive-therapeutics-announce-u-s-licensing-and-supply-deal-for-riluzole-oral-film-for-als-treatment/ 2021-01-22T10:57:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Mitsubishi-Logo.jpg http://www.pharmajournalist.com/gritstone-advances-second-generation-covid-19-vaccine-coral-program-with-support-from-niaid-program-has-potential-to-protect-against-mutant-variants-of-sars-cov-2/ 2021-01-22T11:00:35+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/gritstone-oncology-logo.png http://www.pharmajournalist.com/innovent-announces-an-out-license-agreement-with-pt-etana-biotechnologies-indonesia-to-launch-byvasda-bevacizumab-biosimilar-in-indonesia/ 2021-01-22T11:03:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/imfinzi-approved-in-the-eu-for-less-frequent-fixed-dose-use-in-unresectable-non-small-cell-lung-cancer/ 2021-01-22T11:05:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/pfizers-xalkori-crizotinib-approved-by-fda-for-alk-positive-anaplastic-large-cell-lymphoma-in-children-and-young-adults/ 2021-01-22T11:07:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/rna-therapeutics-conference-2021-will-explore-industry-insights-into-how-mrna-is-being-used-to-combat-covid-19/ 2021-01-25T11:47:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/RNA-2021.jpg http://www.pharmajournalist.com/eu-regulatory-landscape-and-the-impact-of-the-fmd-discussed-at-parallel-trade-conference-2021/ 2021-01-25T11:52:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/cphi-p-mec-china-gives-a-glimpse-of-the-success-returning-pharma-events-will-deliver-in-2021/ 2021-01-27T09:14:54+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/1-scaled.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/01/1-scaled.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/01/2-scaled.jpg http://www.pharmajournalist.com/the-new-pre-filled-syringes-east-coast-conference-report-is-now-available-to-download/ 2021-01-27T09:35:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300-x-250.jpg http://www.pharmajournalist.com/ild-summit/ 2021-01-28T10:07:19+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/ILD-Summit-Pharma-Journalist-Banner.png http://www.pharmajournalist.com/ai-driven-drug-repositioning-repurposing-summit/ 2021-01-28T10:10:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/AI-Driven-Drug-Repositioning-and-Repurposing-Summit-Banner.png http://www.pharmajournalist.com/the-oligonucleotides-for-cns-summit-is-the-must-attend-forum-for-focused-discussion-allowing-you-to-discover-cutting-edge-oligonucleotide-research-for-neuromuscular-neurodegenerative-diseases/ 2021-01-28T11:02:18+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Oligo-PharmaJournalist-Banner.png http://www.pharmajournalist.com/free-to-attend-for-drug-developers-researchers/ 2021-01-28T11:05:58+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/CDx-Europe-PharmaJournalist-Banner.png http://www.pharmajournalist.com/running-for-the-3rd-year-this-march-2-4-to-unite-cross-industry-experts-from-nephrology-cardiology-and-endocrinology-the-3rd-ckd3-summit-is-focusing-on-the-question-whats-next/ 2021-01-28T11:44:43+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/CKD3.png http://www.pharmajournalist.com/novavax-covid-19-vaccine-demonstrates-89-3-efficacy-in-uk-phase-3-trial/ 2021-01-29T11:16:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/symbicort-turbuhaler-approved-in-china-as-an-anti-inflammatory-reliever-in-mild-asthma/ 2021-01-29T11:17:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ajinomoto-bio-pharma-services-and-humanigen-expand-manufacturing-agreement-to-support-fill-finish-for-investigational-covid-19-therapeutic-lenzilumab-nearing-completion-of-phase-3-study/ 2021-01-29T11:20:10+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Ajinomoto.jpg http://www.pharmajournalist.com/moderna-confirms-discussions-with-u-s-government-for-additional-100-million-doses-of-the-moderna-covid-19-vaccine/ 2021-01-29T11:21:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/lilly-vir-biotechnology-and-gsk-announce-first-patient-dosed-in-expanded-blaze-4-trial-evaluating-bamlanivimab-ly-cov555-with-vir-7831-gsk4182136-for-covid-19/ 2021-01-29T11:23:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/humanetics-corporation-receives-funding-from-department-of-defense-to-test-drug-against-covid-19/ 2021-01-29T11:26:21+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/humanetics-logo.png http://www.pharmajournalist.com/orphan-drug-designation-granted-to-rezafungin-in-eu-for-the-treatment-of-invasive-candidiasis/ 2021-01-29T11:28:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Mundipharma-Logo.png http://www.pharmajournalist.com/merck-discontinues-development-of-sars-cov-2-covid-19-vaccine-candidates-continues-development-of-two-investigational-therapeutic-candidates/ 2021-01-29T11:29:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/moderna-covid-19-vaccine-retains-neutralizing-activity-against-emerging-variants-first-identified-in-the-u-k-and-the-republic-of-south-africa/ 2021-01-29T11:31:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/elasmogen-announces-a-panel-of-novel-potent-anti-covid-19-therapeutic-candidates-identified-through-collaboration-with-u-s-research-partners/ 2021-01-29T11:33:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/lilly-completes-acquisition-of-prevail-therapeutics/ 2021-01-29T11:35:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/sanofi-to-provide-support-to-biontech-in-manufacturing-their-covid-19-vaccine-to-help-address-public-health-needs/ 2021-01-29T11:42:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/biontech-and-fosun-pharma-receive-authorization-for-emergency-use-in-hong-kong-for-covid-19-vaccine/ 2021-01-29T11:47:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/agenus-enters-into-clinical-collaboration-with-nelum-for-zalifrelimab-combination/ 2021-01-29T11:48:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agenus-logo.jpg http://www.pharmajournalist.com/care-access-research-collaborates-with-astrazeneca-on-phase-iii-clinical-trial-for-covid-19-long-acting-antibody-combination/ 2021-01-29T11:50:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/cognate-bioservices-and-nucleus-biologics-announce-partnership-in-cell-and-gene-therapies/ 2021-01-29T11:52:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/hoth-therapeutics-expands-research-collaboration-agreement-with-weill-cornell-medicine-to-continue-the-advancement-of-ht-003-for-acne-treatment-research/ 2021-01-29T11:54:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Hoth_Logo_New.png http://www.pharmajournalist.com/lilly-and-asahi-kasei-pharma-announce-license-agreement-for-chronic-pain-drug-candidate/ 2021-01-29T11:56:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/evozyne-and-takeda-announce-strategic-collaboration-and-license-agreement/ 2021-01-29T12:05:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/valneva-commences-manufacturing-of-its-inactivated-adjuvanted-covid-19-vaccine-completes-phase-1-2-study-recruitment/ 2021-01-29T12:08:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Valneva-Logo.png http://www.pharmajournalist.com/three-key-start-ups-join-smis-2nd-annual-ai-in-drug-discovery-virtual-conference/ 2021-02-03T11:48:02+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/P-343-AI-in-Drug-Discovery-Sponsor-banner-Dassault-Systemes-CAS-1200x627-1.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/02/P-343-AI-in-Drug-Discovery-Sponsor-banner-Dassault-Systemes-CAS-1200x627-1.jpg http://www.pharmajournalist.com/registration-opens-for-smis-5th-annual-highly-potent-active-pharmaceutical-ingredients-conference-hpapi/ 2021-02-05T09:28:07+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/P-348-HAPAi-2021-Virtual-300x250-1.jpg http://www.pharmajournalist.com/forxiga-approved-in-china-for-heart-failure/ 2021-02-05T12:54:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/moderna-announces-amendment-to-supply-agreement-with-switzerland-for-an-additional-6-million-doses-of-covid-19-vaccine-moderna/ 2021-02-05T13:01:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/singapore-health-sciences-authority-hsa-approves-interim-authorization-of-covid-19-vaccine-moderna-for-use/ 2021-02-05T13:02:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/gsk-and-curevac-to-develop-next-generation-mrna-covid-19-vaccines/ 2021-02-05T13:03:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/aeterna-zentaris-signs-agreement-to-evaluate-oral-covid-19-vaccine/ 2021-02-05T13:08:27+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Aeterna-Zentaris.jpg http://www.pharmajournalist.com/tiziana-announces-completion-of-the-clinical-trial-with-nasally-administered-foralumab-its-proprietary-fully-human-anti-cd3-monoclonal-antibody-for-the-treatment-of-covid-19-patients-in-brazil/ 2021-02-05T13:11:28+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Tiziana-Logo.png http://www.pharmajournalist.com/lilly-partners-with-area-health-systems-to-help-enable-access-to-important-antibody-infusion-therapies-for-covid-19-patients/ 2021-02-05T13:12:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/ampio-announces-early-positive-data-in-phase-1-trial-of-inhaled-ampion-in-covid-19-respiratory-distress/ 2021-02-05T13:15:20+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Ampio-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/novartis-signs-initial-agreement-to-provide-manufacturing-capacity-for-pfizer-biontech-covid-19-vaccine/ 2021-02-05T13:16:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/takeda-completes-sale-of-select-otc-and-non-core-assets-to-hypera-pharma/ 2021-02-05T13:17:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/rigel-awarded-16-5-million-from-u-s-department-of-defense-for-phase-3-clinical-trial-of-fostamatinib-in-covid-19-patients/ 2021-02-05T13:19:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Rigel-Pharma-Logo.png http://www.pharmajournalist.com/phase-1-drug-candidate-glr2007-developed-by-gan-lee-has-been-granted-fast-track-designation-by-the-u-s-fda/ 2021-02-05T13:21:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/zebiai-and-tb-alliance-announce-collaboration-to-apply-ml-driven-discovery-platform-to-tuberculosis-targets/ 2021-02-05T13:23:23+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/zebi-ai-logo.jpg http://www.pharmajournalist.com/evozyne-announces-a-strategic-collaboration-for-development-of-novel-biopharmaceutical-therapeutics/ 2021-02-05T13:25:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/evozyne-logo.png http://www.pharmajournalist.com/ribon-therapeutics-announces-license-agreement-with-ono-pharmaceutical/ 2021-02-05T13:26:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/gilead-sciences-and-gritstone-announce-collaboration-utilizing-gritstones-vaccine-platform-technology-for-hiv-cure/ 2021-02-05T13:27:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/engrail-therapeutics-acquires-neurocycle-therapeutics/ 2021-02-05T13:29:53+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/engrail-therapeutics-logo.png http://www.pharmajournalist.com/matrix-medical-network-collaborates-with-astrazeneca-on-phase-iii-clinical-trial-for-covid-19-long-acting-antibody-combination/ 2021-02-05T13:32:28+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Matrix-Medical-Network-Mobile-Health-Clinic.jpg https://pharmajournalist.com/wp-content/uploads/2021/02/Matrix-Medical-Network-Mobile-Health-Clinic.jpg http://www.pharmajournalist.com/swift-biosciences-accelerates-its-global-expansion-in-china-and-asia-pacific/ 2021-02-05T13:34:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Swift-Biosciences-Logo.jpg http://www.pharmajournalist.com/tcg-lifesciences-expands-its-footprint-to-the-united-states-with-the-establishment-of-its-subsidiary-tcg-greenchem/ 2021-02-05T13:36:50+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/TGC-Lifesciences.jpg http://www.pharmajournalist.com/johnson-johnson-announces-submission-of-application-to-the-fda-for-emergency-use-authorization-of-its-investigational-single-shot-janssen-covid-19-vaccine-candidate/ 2021-02-05T13:38:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/ocugen-and-bharat-biotech-announce-execution-of-definitive-agreement-for-the-commercialization-of-covaxin-in-the-us-market/ 2021-02-05T13:40:25+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Ocugen_Logo.jpg http://www.pharmajournalist.com/wuxi-sta-to-purchase-bristol-myers-squibb-manufacturing-facility-in-couvet-switzerland/ 2021-02-05T13:42:31+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Couvet.jpg https://pharmajournalist.com/wp-content/uploads/2021/02/Couvet.jpg http://www.pharmajournalist.com/registration-opens-for-pre-filled-syringes-west-coast-2021-2/ 2021-02-09T12:26:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/two-exclusive-interviews-release-with-pfizer-and-novo-nordisk-ahead-of-pharmaceutical-microbiology-east-coast-virtual-conference/ 2021-02-11T09:32:58+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/P-345-Pharma-Microbiology-East-Coast-2021-1200x627-Virtual-Strap.jpg http://www.pharmajournalist.com/astrazeneca-and-idt-biologika-sign-letter-of-intent-to-increase-covid-19-vaccine-manufacturing-in-europe-and-secure-long-term-supply-capacity/ 2021-02-12T09:44:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/abbvie-and-caribou-biosciences-announce-collaboration-and-license-agreement-for-car-t-cell-products/ 2021-02-12T09:46:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/algernon-pharmaceuticals-considers-adding-lung-scarring-as-an-additional-endpoint-for-its-phase-2b-3-covid-19-study-protocol/ 2021-02-12T09:49:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/algernon-pharma.png http://www.pharmajournalist.com/lillys-bamlanivimab-ly-cov555-administered-with-etesevimab-ly-cov016-receives-fda-emergency-use-authorization-for-covid-19/ 2021-02-12T09:51:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/next-gen-proteomics-company-nautilus-biotechnology-to-list-on-nasdaq-through-merger-with-arya-sciences-acquisition-corp-iii/ 2021-02-12T09:53:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/pfizer-and-ida-foundation-partner-to-expand-access-to-essential-cancer-treatments-in-70-low-and-lower-middle-income-countries/ 2021-02-12T09:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/freeline-therapeutics-updates-clinical-development-plan-for-its-flt180a-hemophilia-b-program/ 2021-02-12T09:57:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/freeline.png http://www.pharmajournalist.com/veru-reports-positive-phase-2-clinical-results-of-veru-111-in-hospitalized-covid-19-patients-at-high-risk-for-acute-respiratory-distress-syndrome/ 2021-02-12T09:59:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/merck-and-biontech-extend-strategic-partnership-through-accelerated-supply-of-urgently-needed-lipids/ 2021-02-12T10:00:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/novavax-announces-start-of-rolling-review-by-multiple-regulatory-authorities-for-covid-19-vaccine-authorization/ 2021-02-12T10:10:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/ac-immune-initiates-clinical-study-of-first-in-class-diagnostic-for-parkinsons-disease/ 2021-02-12T10:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Ac-Immune.png http://www.pharmajournalist.com/hoth-therapeutics-partners-with-camargo-pharmaceutical-services-for-the-ht-001-ind-a-treatment-for-cancer-patients/ 2021-02-12T10:16:51+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Hoth_Logo.png http://www.pharmajournalist.com/hangzhou-chance-pharmaceuticals-expands-pipeline-with-in-licensing-of-aer901-from-aerami-therapeutics/ 2021-02-12T10:20:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/nuance-pharma-announces-strategic-licensing-deal-with-antibe-therapeutics-in-china/ 2021-02-12T10:24:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/ANTIBE-logo.jpg http://www.pharmajournalist.com/apollomics-inc-and-iterion-therapeutics-announce-exclusive-collaboration-and-license-agreement-to-develop-and-commercialize-tegavivint-in-greater-china/ 2021-02-12T10:26:20+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/apollomics-logos.png http://www.pharmajournalist.com/i2o-therapeutics-announces-research-collaboration-with-sanofi-to-enable-oral-delivery-of-nanobody-based-medicines/ 2021-02-12T10:28:50+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/i2O-Therapeutics-Logo.png http://www.pharmajournalist.com/mindmed-signs-partnership-with-swiss-psychedelic-drug-discovery-startup-mindshift-compounds-ag/ 2021-02-12T10:31:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/MindMed-Logo.jpg http://www.pharmajournalist.com/fda-approves-libtayo-cemiplimab-rwlc-as-first-immunotherapy-indicated-for-patients-with-advanced-basal-cell-carcinoma/ 2021-02-12T10:33:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/molecular-templates-establishes-multi-target-collaboration-with-bristol-myers-squibb-for-the-discovery-and-development-of-next-generation-engineered-toxin-bodies-for-the-treatment-of-cancer/ 2021-02-12T10:36:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/pwc-becomes-a-partner-in-the-medicines-manufacturing-innovation-centre/ 2021-02-12T10:39:40+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/PwC-Logo.jpg http://www.pharmajournalist.com/recipharm-bolsters-biologics-offering/ 2021-02-12T10:40:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/rentschler-biopharma-establishes-center-of-excellence-for-cell-and-gene-therapy-in-the-uk/ 2021-02-12T10:42:45+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Rentschler-Biopharma.jpg http://www.pharmajournalist.com/lipomedix-announces-manufacturing-agreement-with-fordoz-for-promitil/ 2021-02-12T10:46:54+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/lipomedix.jpg http://www.pharmajournalist.com/rotachrom-technologies-partners-with-cyclolab-to-increase-production-of-covid-19-treatment/ 2021-02-12T10:48:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/the-only-b2b-parallel-trade-conference-in-europe-2021/ 2021-02-15T10:59:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/exclusive-interview-released-with-conference-chair-susan-neadle-amgen-ahead-of-pre-filled-syringes-east-coast-2021/ 2021-02-16T10:21:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300-x-250.jpg http://www.pharmajournalist.com/gene-therapy-for-muscular-disorders-sarepta-novartis-solid-bio-genethon-4dmt-more-join-the-line-up/ 2021-02-17T08:37:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/Pharma-J-Banners.png http://www.pharmajournalist.com/agenda-revealed-sting-tlr-targeting-therapies-summit-2021/ 2021-02-18T08:36:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/STING-TLR-Pharma-J-300-x-250.png http://www.pharmajournalist.com/interactive-pre-conference-workshop-announced-for-injectable-drug-delivery-2021/ 2021-02-18T08:43:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/400X300.jpg http://www.pharmajournalist.com/pfizer-and-biontech-commence-global-clinical-trial-to-evaluate-covid-19-vaccine-in-pregnant-women/ 2021-02-19T09:55:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/altimmune-announces-fda-clearance-of-adcovid-ind-application/ 2021-02-19T09:57:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/gsk-and-vir-biotechnology-expand-coronavirus-collaboration-to-advance-new-therapeutics-for-influenza-and-other-respiratory-viruses/ 2021-02-19T09:59:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/anixa-biosciences-begins-animal-testing-of-covid-19-therapeutic-candidates/ 2021-02-19T10:01:35+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/anixa-biosciences-logo.png http://www.pharmajournalist.com/johnson-johnson-announces-submission-of-european-conditional-marketing-authorisation-application-to-the-ema-for-its-investigational-single-shot-janssen-covid-19-vaccine-candidate/ 2021-02-19T10:03:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/novavax-announces-expanded-collaboration-and-license-agreement-with-sk-bioscience-for-40-million-doses-of-covid-19-vaccine-for-south-korea/ 2021-02-19T10:20:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/astrazeneca-covid-19-vaccine-authorised-for-emergency-use-by-the-world-health-organization/ 2021-02-19T10:22:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/fda-approves-drug-to-reduce-bone-marrow-suppression-caused-by-chemotherapy/ 2021-02-19T10:28:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/avexegen-therapeutics-receives-a-2-94m-nih-grant-to-advance-treatment-for-inflammatory-bowel-disease/ 2021-02-19T10:32:38+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Avexegen.jpg http://www.pharmajournalist.com/shepherd-therapeutics-and-oncoheroes-biosciences-to-partner-for-the-discovery-development-and-commercialization-of-oncology-therapeutics-for-rare-cancers/ 2021-02-19T10:35:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/iterion-therapeutics-secures-17-million-to-advance-development-of-tegavivint-in-multiple-tumor-settings/ 2021-02-19T10:38:38+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/iterion-therapeutics-logo.jpg http://www.pharmajournalist.com/alivecor-announces-collaboration-with-astrazeneca-to-develop-non-invasive-potassium-monitoring-solutions/ 2021-02-19T10:41:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/provention-bio-and-huadong-announce-strategic-collaboration-to-develop-and-commercialize-prv-3279-in-greater-china/ 2021-02-19T10:42:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/provention-Bio-Logo.jpg http://www.pharmajournalist.com/boston-immune-technologies-and-therapeutics-and-beigene-enter-into-an-exclusive-option-and-license-agreement-to-develop-novel-tnfr2-antagonists/ 2021-02-19T10:44:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/lilly-and-rigel-enter-strategic-collaboration-to-develop-ripk1-inhibitors-for-the-potential-treatment-of-immunological-and-neurodegenerative-diseases/ 2021-02-19T10:46:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/novartis-entresto-granted-expanded-indication-in-chronic-heart-failure-by-fda/ 2021-02-19T10:48:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/exclusive-chair-interview-with-justin-mason-home-ahead-of-smis-5th-annual-highly-potent-active-pharmaceutical-ingredients-conference-hpapi/ 2021-02-19T10:52:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/P-348-HAPAi-2021-Virtual-1200x627-1.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/02/P-348-HAPAi-2021-Virtual-1200x627-1.jpg http://www.pharmajournalist.com/registration-is-open-for-smis-4th-annual-pharmaceutical-microbiology-west-coast-2021/ 2021-02-24T08:35:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/P-322-Pharma-Microbiology-WC-2021-Virtual-640x360-1.jpg https://pharmajournalist.com/wp-content/uploads/2021/02/P-322-Pharma-Microbiology-WC-2021-Virtual-640x360-1.jpg http://www.pharmajournalist.com/voluntary-withdrawal-of-imfinzi-indication-in-advanced-bladder-cancer-in-the-us/ 2021-02-26T09:06:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ucb-and-microsoft-expand-collaboration-to-accelerate-drug-discovery-and-development/ 2021-02-26T09:07:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/sanofi-and-gsk-initiate-new-phase-2-study-of-their-adjuvanted-recombinant-protein-based-covid-19-vaccine-candidate/ 2021-02-26T09:10:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/novavax-completes-enrollment-of-prevent-19-covid-19-vaccine-pivotal-phase-3-trial-in-the-united-states-and-mexico/ 2021-02-26T09:12:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/welldoc-and-lilly-collaborate-to-integrate-bluestar-app-capabilities-into-lillys-connected-insulin-solutions/ 2021-02-26T09:15:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/nmpa-approves-toripalimab-in-patients-with-recurrent-or-metastatic-nasopharyngeal-carcinoma-after-failure-of-at-least-two-lines-of-prior-systemic-therapy/ 2021-02-26T09:17:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Junshi-Biosciences.jpeg http://www.pharmajournalist.com/sunrock-biopharma-and-genscript-probio-enter-into-a-collaboration-agreement-to-develop-novel-monoclonal-antibody-program/ 2021-02-26T09:19:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/GenScript.jpg http://www.pharmajournalist.com/compugen-expands-clinical-collaboration-agreement-with-bristol-myers-squibb-with-phase-1b-combination-study-of-com701-with-opdivo/ 2021-02-26T09:22:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/adaptive-biotechnologies-expands-collaboration-with-labcorp-to-increase-access-to-growing-research-and-clinical-diagnostic-portfolio/ 2021-02-26T09:24:49+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/sirion-biotech-announces-collaboration-with-sanofi-to-innovate-gene-therapy-treatments-with-improved-adeno-associated-virus-capsids/ 2021-02-26T09:28:23+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Sirion-Biotech-Logo.jpg http://www.pharmajournalist.com/daiichi-sankyo-and-lysa-lysarc-calym-enter-research-collaboration-for-valemetostat-in-patients-with-relapsed-refractory-b-cell-lymphoma/ 2021-02-26T09:30:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/inovio-and-qiagen-expand-collaboration-to-develop-next-generation-sequencing-ngs-companion-diagnostic-for-inovios-vgx-3100-for-advanced-cervical-dysplasia/ 2021-02-26T09:33:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/xencor-and-ucla-enter-collaboration-to-discover-and-develop-novel-xmab-therapeutics/ 2021-02-26T09:36:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/shepherd-therapeutics-and-mayo-clinic-announce-collaboration-to-advance-research-in-rhabdomyosarcoma-using-shepherds-precision-oncology-platform-delve/ 2021-02-26T09:38:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/fda-accepts-for-priority-review-pfizers-application-for-ticovac-tick-borne-encephalitis-vaccine/ 2021-02-26T09:41:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/amri-joins-network-of-approved-manufacturers-of-lipid-excipients-for-pfizer-biontech-covid-19-vaccine/ 2021-02-26T10:00:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/amriglobal.jpg http://www.pharmajournalist.com/covectra-introduces-next-generation-stellaguard-smart-label-and-mobile-authentication-solution-to-combat-counterfeiting-of-products/ 2021-02-26T10:06:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/StellaGuard.jpg https://pharmajournalist.com/wp-content/uploads/2021/02/StellaGuard.jpg http://www.pharmajournalist.com/crownbio-and-jsr-life-sciences-partner-with-cambridge-quantum-computing-to-leverage-quantum-machine-learning-for-novel-cancer-treatment-biomarker-discovery/ 2021-02-26T10:14:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/altasciences-performs-phase-i-studies-for-fda-approval-of-vibegron/ 2021-02-26T10:17:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/AltaSciences-Logo.jpg http://www.pharmajournalist.com/seven-bridges-selected-by-pfizer-to-support-data-management-solution-for-single-cell-rna-sequencing-data/ 2021-02-26T10:20:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/SevenBridges-Logo.png http://www.pharmajournalist.com/how-a-hard-brexit-will-impact-the-eu-market-and-the-effects-of-parallel-trade-practices/ 2021-03-01T13:27:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/conference-co-chairs-invite-you-to-attend-pre-filled-syringes-west-coast-2021/ 2021-03-02T10:38:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/ema-starts-rolling-review-of-the-sputnik-v-covid-19-vaccine/ 2021-03-05T08:55:48+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/EMA.jpg http://www.pharmajournalist.com/fda-expands-approval-of-pfizers-lorbrena-as-first-line-treatment-for-alk-positive-metastatic-lung-cancer/ 2021-03-05T08:57:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/vir-biotechnology-and-gsk-provide-update-on-nih-sponsored-activ-3-trial-evaluating-vir-7831-in-hospitalized-adults-with-covid-19/ 2021-03-05T09:02:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/VIR-Logo.jpg http://www.pharmajournalist.com/merck-to-help-produce-johnson-barda-to-provide-merck-with-funding-to-expand-mercks-manufacturing-capacity-for-covid-19-vaccines-and-medicines/ 2021-03-05T09:03:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/obviohealth-and-redhill-biopharma-launch-first-in-kind-remote-covid-19-therapy-trial-incorporating-highest-level-of-at-home-patient-monitoring-to-date/ 2021-03-05T09:07:23+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/obviohealth.png http://www.pharmajournalist.com/wuxi-apptec-completes-acquisition-of-oxgene-to-further-strengthen-cell-and-gene-therapy-service-offerings-for-global-customers/ 2021-03-05T09:09:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/WuXi-AppTec.jpg http://www.pharmajournalist.com/cerecor-announces-cerc-002-significantly-reduced-respiratory-failure-and-mortality-in-phase-2-clinical-trial-in-patients-hospitalized-with-covid-19-ards/ 2021-03-05T09:12:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Cerecor-Logo.png http://www.pharmajournalist.com/takeda-secures-global-rights-from-ovid-therapeutics-to-develop-and-commercialize-soticlestat-for-the-treatment-of-children-and-adults-with-dravet-syndrome-and-lennox-gastaut-syndrome/ 2021-03-05T09:14:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/sarpac-clinical-trial-of-leukine-sargramostim-rhu-gm-csf-in-hospitalized-covid-19-patients-meets-primary-endpoint-of-significant-improvement-in-lung-function/ 2021-03-05T09:17:32+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Partner-Therapeutics-Logo.jpg http://www.pharmajournalist.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-use/ 2021-03-05T09:21:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/hitgen-and-uppthera-enter-into-drug-discovery-research-collaboration/ 2021-03-05T09:24:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/phio-pharmaceuticals-and-agonox-inc-announce-collaboration-on-clinical-development-of-novel-t-cell-based-cancer-immunotherapies/ 2021-03-05T09:27:02+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Phio-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/debiopharm-grants-a-worldwide-exclusive-license-to-merck-kgaa-darmstadt-germany-for-the-development-and-commercialization-of-xevinapant/ 2021-03-05T09:29:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Debiopharm-Logo.png http://www.pharmajournalist.com/oscotec-and-beactica-therapeutics-announce-license-and-collaboration-agreement-to-develop-new-cancer-drug/ 2021-03-05T09:32:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/iktos-announces-collaboration-with-pfizer-in-ai-for-drug-design/ 2021-03-05T09:33:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement-for-the-development-and-commercialization-of-novel-immunotherapeutic-oncolytic-viruses-for-treatment-of-cancer/ 2021-03-05T09:35:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/eisai-to-support-construction-of-screening-framework-for-the-novel-coronavirus-infection-in-kenya/ 2021-03-05T09:37:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/EISAI.jpg http://www.pharmajournalist.com/tempest-therapeutics-announces-clinical-collaboration-with-roche-to-advance-tpst-1120-into-a-randomized-combination-study-in-first-line-hepatocellular-carcinoma/ 2021-03-05T09:39:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/alx-oncology-and-tallac-therapeutics-announce-collaboration-on-novel-class-of-cancer-immunotherapeutics/ 2021-03-05T09:41:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/conserv-bioscience-and-etherna-immunotherapies-to-collaborate-on-development-of-mrna-vaccines-for-infectious-diseases/ 2021-03-05T09:43:49+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/amgen-to-acquire-five-prime-therapeutics-for-1-9-billion-in-cash/ 2021-03-05T09:46:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/boehringer-ingelheim-and-gubra-join-forces-to-identify-and-validate-innovative-peptides-for-the-treatment-of-obesity/ 2021-03-05T09:48:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/just-under-2-weeks-until-smis-2nd-annual-ai-in-drug-delivery-2021-sponsored-by-cas-dassault-systemes-and-gero/ 2021-03-05T12:32:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/P-343-AI-in-Drug-Discovery-Virtual-Conference-300x250-1.jpg http://www.pharmajournalist.com/advanced-modalities-and-formulation-discussed-at-injectable-drug-delivery-conference-2021/ 2021-03-09T08:38:29+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/400X300.jpg http://www.pharmajournalist.com/lynne-ensor-parexel-chair-of-smis-4th-annual-pharmaceutical-microbiology-east-coast-conference-exclusive-interview-released/ 2021-03-11T09:53:37+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/1200x627-Chair-Lynne-Ensor-Banner.jpg http://www.pharmajournalist.com/novavax-confirms-high-levels-of-efficacy-against-original-and-variant-covid-19-strains-in-united-kingdom-and-south-africa-trials/ 2021-03-12T09:04:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/cepi-and-vbi-vaccines-collaborate-to-advance-vaccine-candidates-against-covid-19-variants/ 2021-03-12T09:08:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/enveric-biosciences-signs-definitive-agreement-to-acquire-exclusive-license-for-novel-molecules-from-diverse-biotech/ 2021-03-12T09:11:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Enveric-Logo.png http://www.pharmajournalist.com/melior-pharmaceuticals-receives-ind-clearance-from-us-fda-for-covid-19-therapeutic/ 2021-03-12T09:14:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Melior_Pharm_Logo.jpg http://www.pharmajournalist.com/takeda-to-acquire-maverick-therapeutics-to-advance-t-cell-engager-therapies-for-solid-tumors-and-expand-novel-immuno-oncology-portfolio/ 2021-03-12T09:17:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/vbi-vaccines-announces-initiation-of-enrollment-in-adaptive-phase-1-2-study-of-prophylactic-covid-19-vaccine-candidate-vbi-2902/ 2021-03-12T09:20:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/valo-therapeutics-and-immunoscape-collaboration-identifies-immunogenic-peptides-to-develop-pan-coronavirus-vaccine/ 2021-03-12T09:23:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Valo-Therapeutics-Logo.jpeg http://www.pharmajournalist.com/roche-provides-update-on-tecentriq-us-indication-in-prior-platinum-treated-metastatic-bladder-cancer/ 2021-03-12T09:31:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/novartis-provides-update-on-phase-iii-study-evaluating-canakinumab-acz885-as-second-or-third-line-treatment-in-combination-with-chemotherapy-in-non-small-cell-lung-cancer-2/ 2021-03-12T09:35:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/ema-issues-advice-on-lillys-bamlanivimab-ly-cov555-alone-and-administered-together-with-etesevimab-ly-cov016-for-the-treatment-of-confirmed-covid-19-in-the-european-union/ 2021-03-12T09:37:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/can-fite-enrolls-first-patient-in-phase-ii-covid-19-study-under-fda-protocol/ 2021-03-12T09:39:36+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Can-Fite_logo.jpg http://www.pharmajournalist.com/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir/ 2021-03-12T09:41:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/exelixis-enters-into-exclusive-license-agreement-with-wuxi-biologics-to-support-further-expansion-of-its-growing-oncology-biologics-pipeline/ 2021-03-12T09:43:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/lilly-and-biolojic-design-announce-research-collaboration-to-discover-and-develop-antibody-therapies-for-diabetes/ 2021-03-12T09:44:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/neurorx-and-tff-pharmaceuticals-announce-entering-into-feasibility-collaboration/ 2021-03-12T10:00:48+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/NeuroRx.png http://www.pharmajournalist.com/sparta-biopharma-announces-us-commercial-availability-of-bioenthesis-for-rotator-cuff-repair/ 2021-03-12T10:05:11+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Sparta-Biopharma-Logo.jpg http://www.pharmajournalist.com/complix-signs-global-drug-discovery-and-development-agreement-with-i-mab-to-develop-cell-penetrating-alphabodies-against-two-intracellular-immuno-oncology-targets/ 2021-03-12T10:08:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/orgenesis-enters-second-phase-of-collaboration-with-hospital-infantil-universitario-nino-jesus-in-madrid-with-exclusive-license-to-commercialize-celyvir-solid-tumor-therapy/ 2021-03-12T10:11:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/phasebio-pharmaceuticals-and-biovectra-enter-into-supply-agreement-to-support-development-and-commercialization-of-bentracimab/ 2021-03-12T10:15:05+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/PhaseBio-Logo.jpg http://www.pharmajournalist.com/exclusive-interview-with-david-guest-mhra-ahead-of-parallel-trade-conference-2021/ 2021-03-15T11:48:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/explore-opportunities-and-strategies-for-convergence-in-the-combination-products-space-at-pre-filled-syringes-east-coast-2021/ 2021-03-15T13:05:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300-x-250.jpg http://www.pharmajournalist.com/invitation-from-michael-scherz-and-naheed-mirza-co-chairs-at-pain-therapeutics-2021/ 2021-03-18T09:01:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/1200x627-P-347-Pain-Therapeutics-Joint-Chairs-banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/03/1200x627-P-347-Pain-Therapeutics-Joint-Chairs-banner.jpg http://www.pharmajournalist.com/uk-and-eu-regulatory-agencies-confirm-covid-19-vaccine-astrazeneca-is-safe-and-effective/ 2021-03-19T08:03:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/hoth-therapeutics-partners-with-university-of-cincinnati-to-perform-critical-studies-for-streamlined-development-of-novel-antibiotic-ht-006/ 2021-03-19T08:04:41+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Hoth_Logo.png http://www.pharmajournalist.com/merck-receives-priority-review-from-fda-for-new-drug-application-for-hif-2%ce%b1-inhibitor-belzutifan-mk-6482/ 2021-03-19T08:06:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/invite-from-justin-mason-home-chair-at-smis-5th-annual-highly-potent-active-pharmaceutical-ingredients-2021/ 2021-03-19T08:09:21+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/P-348-Justin-Mason-Home-Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/03/P-348-Justin-Mason-Home-Banner.jpg http://www.pharmajournalist.com/tonix-pharmaceuticals-reports-positive-covid-19-vaccine-efficacy-results-in-non-human-primates-vaccinated-with-tnx-1800-and-challenged-with-live-sars-cov-2/ 2021-03-19T08:09:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/tonix-pharmaceuticals.png http://www.pharmajournalist.com/astrazeneca-to-supply-the-us-with-up-to-half-a-million-additional-doses-of-the-potential-covid-19-antibody-treatment-azd7442/ 2021-03-19T08:11:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/aurinia-announces-positive-cost-effectiveness-assessment-of-lupkynis-voclosporin-in-latest-icer-draft-evidence-report/ 2021-03-19T08:18:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aurinia-Pharma-Logo.jpg http://www.pharmajournalist.com/ampio-pharmaceuticals-details-early-positive-results-for-inhaled-ampion-in-covid-19-respiratory-distress/ 2021-03-19T08:20:20+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Ampio-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/new-zolgensma-data-demonstrate-age-appropriate-development-when-used-early-real-world-benefit-in-older-children-and-durability-5-years-post-treatment/ 2021-03-19T08:22:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/moderna-announces-first-participants-dosed-in-phase-2-3-study-of-covid-19-vaccine-candidate-in-pediatric-population/ 2021-03-19T08:25:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/hepatx-namocell-and-takara-bio-usa-complete-second-phase-of-collaboration-on-single-cell-analysis-for-cell-therapy-to-treat-late-stage-liver-diseases/ 2021-03-19T08:28:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/gilead-and-merck-announce-agreement-to-jointly-develop-and-commercialize-long-acting-investigational-treatment-combinations-of-lenacapavir-and-islatravir-in-hiv/ 2021-03-19T08:30:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/takeda-and-idt-support-manufacturing-of-johnson-johnsons-covid-19-vaccine/ 2021-03-19T08:32:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/nurix-therapeutics-announces-collaboration-for-the-discovery-of-novel-drugs-to-treat-pediatric-cancers/ 2021-03-19T08:36:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Nurix-Logo.jpg http://www.pharmajournalist.com/wuxi-biologics-to-acquire-biologics-ds-and-dp-manufacturing-facilities-from-pfizer-china/ 2021-03-19T10:37:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/valence-discovery-to-support-repare-therapeutics-on-ai-enabled-drug-discovery-in-precision-oncology/ 2021-03-19T10:44:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Valence-Logo.jpg http://www.pharmajournalist.com/m2gen-announces-new-collaboration-with-merck-to-advance-cancer-therapies/ 2021-03-19T10:46:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/boston-pharmaceuticals-enters-into-unique-multi-year-out-license-and-option-agreement-with-gsk-for-the-advancement-of-multiple-pre-phase-2-programs/ 2021-03-19T10:49:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/pyxis-oncology-announces-worldwide-licensing-agreement-with-pfizer-to-develop-and-commercialize-multiple-antibody-drug-conjugates/ 2021-03-19T10:52:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ambrx-granted-orphan-drug-designation-for-arx788-for-the-treatment-of-gastric-cancer/ 2021-03-19T10:58:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Ambrx-Logo.jpg http://www.pharmajournalist.com/azd1222-us-phase-iii-trial-met-primary-efficacy-endpoint-in-preventing-covid-19-at-interim-analysis/ 2021-03-26T09:33:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/vertex-receives-australian-tga-approval-for-trikafta/ 2021-03-26T09:38:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/invite-from-jim-polarine-and-geeta-singh-co-chairs-to-join-pharmaceutical-microbiology-west-coast-virtual-conference/ 2021-03-26T09:42:07+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/1200x627-joint-chairs-2021.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/03/1200x627-joint-chairs-2021.jpg http://www.pharmajournalist.com/step-pharma-raises-eur35-million-in-series-b-financing-to-advance-first-in-class-ctps1-inhibitor-into-the-clinic-in-t-cell-malignancies/ 2021-03-26T09:55:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/potential-covid-19-treatment-identified-in-ucla-led-lab-study/ 2021-03-26T10:00:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/boehringer-ingelheim-sees-positive-business-momentum-in-2020-despite-impact-of-covid-19/ 2021-03-26T10:03:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/nice-publishes-single-guideline-for-managing-covid-19/ 2021-03-26T10:05:28+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/COVID-guideline-image.png http://www.pharmajournalist.com/wp-content/uploads/2021/03/COVID-guideline-image.png http://www.pharmajournalist.com/clover-biopharmaceuticals-and-dynavax-announce-first-participants-dosed-in-spectra-a-global-phase-2-3-clinical-trial-for-adjuvanted-s-trimer-covid-19-vaccine-candidate/ 2021-03-26T10:07:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/sanofi-continues-streamlining-of-established-products-with-sale-of-anti-inflammatory-drugs-to-fidia-farmaceutici/ 2021-03-26T10:16:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/pfizer-initiates-phase-1-study-of-novel-oral-antiviral-therapeutic-agent-against-sars-cov-2/ 2021-03-26T10:18:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/komodo-health-secures-220m-in-funding-led-by-tiger-global/ 2021-03-26T10:21:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/ema-advises-against-use-of-ivermectin-for-the-prevention-or-treatment-of-covid-19-outside-randomised-clinical-trials/ 2021-03-26T10:23:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/EMA.jpg http://www.pharmajournalist.com/bioage-initiates-phase-2-trial-of-bge-175-to-treat-covid-19-by-reversing-immune-aging/ 2021-03-26T10:25:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Bioage.jpg http://www.pharmajournalist.com/oramed-forms-a-joint-venture-oravax-medical-inc-for-the-development-of-novel-oral-covid-19-vaccines/ 2021-03-26T10:29:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/fda-approves-janssens-ponvory-for-relapsing-multiple-sclerosis/ 2021-03-26T10:32:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/twist-bioscience-and-kyowa-kirin-partner-for-gpcr-antibody-discovery/ 2021-03-26T10:34:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Twist-Bioscience-logo.jpg http://www.pharmajournalist.com/indivumed-announces-expansion-into-drug-development-formation-of-ix-therapeutics/ 2021-03-26T10:37:19+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/indivumed-logo.jpg http://www.pharmajournalist.com/everest-medicines-announces-acceptance-of-new-drug-application-by-china-nmpa-for-xerava-for-the-treatment-of-complicated-intra-abdominal-infections/ 2021-03-26T10:41:10+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Everest-Medicines-Logo.jpg http://www.pharmajournalist.com/relief-and-acer-therapeutics-sign-collaboration-and-license-agreement-for-worldwide-development-and-commercialization-of-acer-001-for-the-treatment-of-urea-cycle-disorders-and-maple-syrup-urine-diseas/ 2021-03-26T10:42:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/semathera-enters-into-a-research-collaboration-and-exclusive-license-agreement-with-roche/ 2021-03-26T10:44:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/dunad-therapeutics-emerges-to-develop-next-generation-small-molecule-therapeutics-based-on-first-tuneable-targeted-protein-degradation-technology/ 2021-03-26T10:48:53+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Dunad-Therapeutics-Logo.jpg http://www.pharmajournalist.com/cipla-therapeutics-and-siga-technologies-announce-strategic-partnership-to-support-innovation-and-provide-access-to-novel-antibacterial-drugs-against-biothreats/ 2021-03-26T10:51:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cipla-Logo.png http://www.pharmajournalist.com/exacis-biotherapeutics-develops-mrna-engineered-ipsc-derived-nk-cells-for-difficult-to-treat-tumors/ 2021-03-26T10:55:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Exacis-Biotherapeutics-Logo.png http://www.pharmajournalist.com/biopharmaceutical-and-technology-leaders-form-collaboration-to-promote-standards-and-a-modern-patient-id-for-advanced-therapies/ 2021-03-26T10:59:07+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Vineti-Logo.jpg http://www.pharmajournalist.com/bright-peak-therapeutics-inc-and-ajinomoto-co-inc-enter-into-a-research-collaboration-and-license-agreement-to-create-novel-immunocytokines/ 2021-03-26T11:02:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/how-has-the-pfs-industry-adapted-to-the-shift-towards-connectivity-and-digital-health/ 2021-03-29T11:39:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300-x-250.jpg http://www.pharmajournalist.com/takeda-completes-sale-of-four-diabetes-products-in-japan-to-teijin-pharma-limited/ 2021-04-02T10:57:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/iconovo-signs-agreement-with-isr-for-the-development-of-inhaled-covid-19-vaccine/ 2021-04-02T10:59:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/nih-clinical-trial-evaluating-moderna-covid-19-variant-vaccine-begins/ 2021-04-02T15:27:42+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/20210331-covid.jpg https://pharmajournalist.com/wp-content/uploads/2021/04/20210331-covid.jpg http://www.pharmajournalist.com/pfizer-biontech-announce-positive-topline-results-of-pivotal-covid-19-vaccine-study-in-adolescents/ 2021-04-02T15:29:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/amgen-to-acquire-rodeo-therapeutics-corporation/ 2021-04-02T15:31:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/novartis-receives-eu-approval-for-kesimpta/ 2021-04-02T15:34:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/celonic-and-curevac-announce-agreement-to-manufacture-over-100-million-doses-of-curevacs-covid-19-vaccine-candidate-cvncov/ 2021-04-02T16:00:10+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Celonic_CureVac.png https://pharmajournalist.com/wp-content/uploads/2021/04/Celonic_CureVac.png http://www.pharmajournalist.com/roches-evrysdi-approved-by-european-commission-as-first-and-only-at-home-treatment-for-spinal-muscular-atrophy/ 2021-04-02T16:01:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/johnson-johnson-announces-advance-purchase-agreement-with-the-african-vaccine-acquisition-trust-for-the-companys-covid-19-vaccine-candidate/ 2021-04-02T16:04:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/lilly-vir-biotechnology-and-gsk-announce-positive-topline-data-from-the-phase-2-blaze-4-trial-evaluating-bamlanivimab-with-vir-7831-in-low-risk-adults-with-covid-19/ 2021-04-02T16:06:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/humanigen-reports-positive-phase-3-topline-results-demonstrating-that-lenzilumab-improves-survival-without-need-for-mechanical-ventilation-in-hospitalized-patients-with-covid-19/ 2021-04-02T16:08:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Humanigen_Logo.jpg http://www.pharmajournalist.com/gsk-and-vir-biotechnology-announce-submission-of-emergency-use-authorization-request-to-fda-for-vir-7831-for-the-early-treatment-of-covid-19/ 2021-04-02T16:10:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/ema-issues-advice-on-the-use-of-celltrions-anti-covid-19-monoclonal-antibody-treatment-regdanvimab-ct-p59-for-covid-19-patients-in-the-european-union/ 2021-04-29T16:43:16+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/EMA.jpg http://www.pharmajournalist.com/bioasis-technologies-inc-and-aposense-enter-into-a-research-collaboration/ 2021-04-02T16:47:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/astellas-receives-positive-chmp-opinion-for-xtanditm-enzalutamide-for-patients-with-metastatic-hormone-sensitive-prostate-cancer/ 2021-04-02T16:49:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/hansa-biopharma-enters-preclinical-research-collaboration-with-argenx/ 2021-04-02T16:52:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/tarsus-pharmaceuticals-and-lianbio-announce-strategic-partnership-to-develop-and-commercialize-tp-03-in-greater-china-for-the-treatment-of-demodex-blepharitis-and-meibomian-gland-disease/ 2021-04-02T16:57:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Tarsus_Logo.jpg http://www.pharmajournalist.com/applied-biomath-llc-announces-collaboration-with-asher-biotherapeutics-for-systems-pharmacology-modeling-in-oncology/ 2021-04-02T17:00:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/applied-biomath-logo.png http://www.pharmajournalist.com/bridgene-biosciences-announces-research-collaboration-with-takeda-to-discover-small-molecule-drugs-for-undruggable-targets/ 2021-04-02T17:02:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/piramal-pharma-ltd-to-acquire-100-stake-in-hemmo-pharmaceuticals/ 2021-04-02T17:06:18+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Hemmo_site.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/04/Hemmo_site.jpg http://www.pharmajournalist.com/fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-multiple-myeloma/ 2021-04-02T17:08:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/servier-completes-acquisition-of-agios-pharmaceuticals-oncology-business/ 2021-04-02T17:11:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png http://www.pharmajournalist.com/engage-in-industry-case-studies-on-design-controls-human-factors-and-parenteral-formulation/ 2021-04-07T11:13:19+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/400X300.jpg http://www.pharmajournalist.com/fda-keynote-speakers-at-smis-4th-annual-pharmaceutical-microbiology-east-coast-virtual-conference-in-3-weeks/ 2021-04-08T08:44:36+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/P-345-1200x627-LC3weeks.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/04/P-345-1200x627-LC3weeks.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-with-achim-kless-pain-genetics-lead-from-eli-lilly-company-ahead-of-pain-therapeutics/ 2021-04-09T10:01:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/1200x627-P-347-Pain-Therapeutics-Achim-Kless-banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/04/1200x627-P-347-Pain-Therapeutics-Achim-Kless-banner.jpg http://www.pharmajournalist.com/lilly-and-incyte-announce-results-from-the-phase-3-cov-barrier-study-of-baricitinib-in-hospitalized-covid-19-patients/ 2021-04-09T10:33:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/cytodyn-signs-exclusive-supply-and-distribution-agreement-with-biomm-s-a-in-brazil-for-covid-19-and-all-other-leronlimab-indications/ 2021-04-09T10:36:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/aim-immunotech-announces-positive-safety-data-in-first-cohort-of-phase-1-clinical-study-investigating-intranasal-administration-of-ampligen-as-a-potential-prophylaxis-or-treatment-for-covid-19-and-oth/ 2021-04-09T10:43:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/AIM-ImmunoTech.jpg http://www.pharmajournalist.com/icosavax-closes-100-million-series-b-financing-to-advance-bivalent-rsv-hmpv-vaccine-candidate-into-clinical-trials/ 2021-04-09T10:50:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/ab-science-announces-the-signing-of-an-exclusive-licensing-agreement-with-the-university-of-chicago-to-conduct-research-for-the-prevention-and-treatment-of-covid-19/ 2021-04-09T10:54:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sound-pharmaceuticals-awarded-3-1m-nih-grant-to-test-spi-1005-in-covid-19/ 2021-04-09T11:03:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Sound-Pharma-Logo.jpg http://www.pharmajournalist.com/valneva-reports-positive-phase-1-2-data-for-its-inactivated-adjuvanted-covid-19-vaccine-candidate-vla2001/ 2021-04-09T11:06:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Valneva-Logo.png http://www.pharmajournalist.com/innovation-pharma-completes-interim-safety-data-review-dmc-approves-increased-dosing-frequency-in-phase-2-clinical-trial-of-brilacidin-in-hospitalized-covid-19-patients/ 2021-04-09T11:08:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/anixa-biosciences-and-ontochem-enter-next-stage-of-development-for-covid-19-therapeutic/ 2021-04-09T11:13:54+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/anixa-biosciences-logo.png http://www.pharmajournalist.com/novavax-initiates-covid-19-vaccine-clinical-trial-crossover/ 2021-04-09T11:16:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/sorrento-enters-into-merger-agreement-to-acquire-late-stage-oncology-company-acea-therapeutics/ 2021-04-09T11:19:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/cidara-therapeutics-announces-agreement-with-janssen-to-develop-and-commercialize-avcs-for-the-prevention-and-treatment-of-influenza/ 2021-04-09T11:23:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/CIDARA-THERAPEUTICS.png http://www.pharmajournalist.com/hadassah-and-mybiotics-to-collaborate-for-the-discovery-of-microbiome-based-therapy-for-improving-cancer-immunotherapy/ 2021-04-09T11:29:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/progenity-and-ionis-pharmaceuticals-enter-into-agreement-to-evaluate-progenitys-ingestible-oral-biotherapeutics-technology-for-delivery-of-antisense-therapies/ 2021-04-09T11:34:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/shanghai-genechem-co-ltd-genechem-announces-global-collaboration-on-bispecific-antibodies/ 2021-04-09T11:37:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/context-therapeutics-and-integral-molecular-enter-collaboration-and-license-deal-for-novel-claudin-6-antibodies-for-gynecologic-cancer-therapeutic-program/ 2021-04-09T11:46:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/celcuity-announces-worldwide-licensing-agreement-with-pfizer-to-develop-and-commercialize-gedatolisib/ 2021-04-09T11:53:35+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Celcuity-Logo.png http://www.pharmajournalist.com/occupational-toxicology-and-placing-worker-safety-at-the-forefront-to-be-discussed-at-hpapi-conference/ 2021-04-09T15:56:38+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/P-348-Joint-Sponsors-banner.jpg http://www.pharmajournalist.com/abbvie-submits-regulatory-applications-for-skyrizi-risankizumab-in-psoriatic-arthritis-to-fda-and-ema/ 2021-04-09T17:20:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/lilly-and-incyte-communicate-review-extension-of-supplemental-new-drug-application-for-baricitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis/ 2021-04-09T17:23:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/ab-science-announces-the-signing-of-an-exclusive-licensing-agreement-with-the-university-of-chicago-to-conduct-research-for-the-prevention-and-treatment-of-covid-19-2/ 2021-04-09T17:26:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/antengene-announces-nmpa-approval-of-ind-application-for-atg-019-in-patients-with-advanced-solid-tumors-or-non-hodgkins-lymphoma/ 2021-04-09T17:29:14+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Antengene-Logo.jpg http://www.pharmajournalist.com/abbvie-announces-extension-of-review-for-supplemental-new-drug-application-of-upadacitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis/ 2021-04-09T17:31:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/pfs-industry-leaders-to-discuss-new-developments-and-showcase-the-latest-advancements-at-pre-filled-syringes-west-coast-2021/ 2021-04-13T10:04:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/top-10-reasons-to-join-smis-4th-annual-pharmaceutical-microbiology-west-coast-conference/ 2021-04-16T08:29:01+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/P-322-Pharma-Micro-WC-Joint-SPEX-Banner-1200x627-1.jpg http://www.pharmajournalist.com/fda-authorizes-new-high-throughput-automated-system-for-leading-covid-19-test/ 2021-04-16T11:33:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-to-acquire-ppd-inc-a-leading-clinical-research-organization/ 2021-04-16T11:34:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/inovios-covid-19-vaccine-candidate-ino-4800-provides-broad-cross-reactive-immune-responses-in-humans-against-variants-of-concern/ 2021-04-16T11:36:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/tango-therapeutics-and-bctg-acquisition-corp-announce-merger-agreement/ 2021-04-16T11:39:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/airway-therapeutics-announces-fda-acceptance-of-ind-for-at-100s-second-indication-in-severe-covid-19-patients/ 2021-04-16T11:43:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/sanofi-to-invest-in-a-leading-edge-production-site-in-singapore-continues-to-strengthen-its-vaccines-manufacturing-capacities/ 2021-04-16T11:46:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/sanofi-acquires-tidal-therapeutics/ 2021-04-16T11:47:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/biogen-and-bio-thera-enter-licencing-agreement-for-arthritis-biosimilar/ 2021-04-16T11:49:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/cansinobio-announces-approval-for-its-single-dose-covid-19-vaccine-convidecia-in-chile/ 2021-04-16T14:32:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/CanSinoBIO-Logo.jpg http://www.pharmajournalist.com/hec-pharm-selects-abec-large-scale-fermenters-to-increase-biopharmaceutical-production-capacity/ 2021-04-16T14:35:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/HEC-Logo.png http://www.pharmajournalist.com/antengene-announces-first-patient-dosed-in-phase-ii-trial-of-atg-008-onatasertib-in-patients-with-advanced-solid-tumors-with-specific-genetic-alterations/ 2021-04-16T14:37:23+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Antengene-Logo.jpg http://www.pharmajournalist.com/spark-therapeutics-enters-collaboration-with-senti-bio-to-bolster-industry-leading-gene-therapy-research-platform/ 2021-04-16T14:39:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/spark-therapeutics.jpg http://www.pharmajournalist.com/abcellera-and-empirico-announce-strategic-multi-target-antibody-discovery-collaboration/ 2021-04-16T14:43:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/abcellera.jpg http://www.pharmajournalist.com/pure-biologics-selects-twist-bioscience-to-expand-phage-display-technology-capabilities/ 2021-04-16T14:45:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/arch-biopartners-enters-into-worldwide-license-agreement-with-telara-pharma-to-re-purpose-cilastatin-for-the-treatment-and-prevention-of-acute-kidney-injury/ 2021-04-16T14:49:01+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Arch-Biopartners-Logo.png http://www.pharmajournalist.com/alligator-bioscience-and-macrogenics-enter-into-a-research-collaboration-to-develop-a-novel-immunotherapy/ 2021-04-16T14:51:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alligator-bioscience-logo.jpg http://www.pharmajournalist.com/gsk-and-vir-biotechnology-announce-ema-review-of-dual-action-monoclonal-antibody-vir-7831-for-the-early-treatment-of-covid-19/ 2021-04-16T14:53:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/scineuro-pharmaceuticals-announces-exclusive-licensing-agreement-with-eli-lilly-company/ 2021-04-16T14:54:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-grants-accelerated-approval-to-trodelvy-for-the-treatment-of-metastatic-urothelial-cancer/ 2021-04-16T14:56:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/registration-is-now-open-for-pre-filled-syringes-san-francisco-conference-2021/ 2021-04-20T08:58:13+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/non-small-cell-lung-cancer-drug-development-summit-new-for-2021/ 2021-04-22T06:36:38+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/NSCLC-Pharma-J-Banner.png http://www.pharmajournalist.com/important-update-the-sting-tlr-targeting-therapies-summit/ 2021-04-22T06:40:10+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/STING-TLR-Pharma-J-300-x-250.png http://www.pharmajournalist.com/registration-is-now-open-for-oligonucleotide-therapeutics-and-delivery-2021/ 2021-04-22T06:48:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/fda-grants-accelerated-approval-for-gsks-jemperli-dostarlimab-gxly-for-women-with-recurrent-or-advanced-dmmr-endometrial-cancer/ 2021-04-23T11:42:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/large-nih-clinical-trial-will-test-polyclonal-antibody-therapeutic-for-covid-19/ 2021-04-23T11:47:48+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/20210421-niaid-activ.jpg http://www.pharmajournalist.com/janux-therapeutics-closes-125-million-series-b-financing-to-advance-next-generation-t-cell-engager-immunotherapies-into-clinical-trials/ 2021-04-23T11:53:22+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/moderna-announces-new-supply-agreement-with-israel-for-2022/ 2021-04-23T11:56:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/johnson-johnson-covid-19-vaccine-roll-out-to-resume-in-europe-following-european-medicines-agency-ema-review/ 2021-04-23T11:58:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/pfizer-and-biontech-to-supply-the-european-union-with-100-million-additional-doses-of-comirnaty/ 2021-04-23T12:00:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-revokes-emergency-use-authorization-for-monoclonal-antibody-bamlanivimab/ 2021-04-23T12:04:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/zenith-epigenetics-announces-clinical-collaboration-with-astellas/ 2021-04-23T12:06:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/vertex-and-obsidian-therapeutics-establish-collaboration-to-discover-novel-therapies-that-regulate-gene-editing/ 2021-04-23T12:08:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/excellthera-and-ossium-health-announce-a-collaboration-to-advance-their-technologies-and-platforms-to-improve-human-health/ 2021-04-23T12:09:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/nanoform-and-aprecia-collaborate-to-advance-3d-printed-nanomedicines/ 2021-04-23T12:12:11+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/nanoform-logo.jpg http://www.pharmajournalist.com/tonix-pharmaceuticals-enters-into-exclusive-worldwide-licensing-agreement-with-oyagen/ 2021-04-23T12:14:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/citrine-medicine-and-sinopharm-group-announce-strategic-partnership-to-broaden-and-accelerate-access-to-rare-disease-drugs-in-china/ 2021-04-23T12:16:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/claritas-announces-agreement-with-cmax-clinical-research-for-phase-1-clinical-study-of-r-107/ 2021-04-23T12:22:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/european-commission-approves-second-indication-of-sarclisa-isatuximab-for-relapsed-multiple-myeloma/ 2021-04-23T12:24:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/pra-health-sciences-expands-its-response-to-covid-19-with-pharmacovigilance-solutions-for-authorized-vaccines-and-therapeutics/ 2021-04-23T12:51:10+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/PRA-Health-Science.png http://www.pharmajournalist.com/valneva-switches-focus-to-bilateral-discussions-to-supply-its-inactivated-adjuvanted-covid-19-vaccine-candidate-vla2001/ 2021-04-23T12:54:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Valneva-Logo.png http://www.pharmajournalist.com/syneos-health-partners-with-medable-expanding-decentralized-solutions-to-bring-clinical-trials-closer-to-the-patient/ 2021-04-23T12:57:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Syneos-Health-Logo.png http://www.pharmajournalist.com/agc-biologics-expands-partnership-with-rocket-pharmaceuticals/ 2021-04-23T12:59:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/adare-pharma-solutions-appoints-ludger-roedder-as-president-adare-biome/ 2021-04-23T13:01:43+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/ADARE-Pharma-Solutions.png http://www.pharmajournalist.com/registration-opens-for-smis-aseptic-processing-conference2021/ 2021-04-23T13:34:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/P-327-Aseptic-Processing-2021-Joint-Sponsors-Banner.jpg http://www.pharmajournalist.com/exclusive-interview-with-director-primary-packaging-process-development-boehringer-ingelheim-released-ahead-of-injectable-drug-delivery-2021/ 2021-04-26T16:10:39+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/400X300.jpg http://www.pharmajournalist.com/join-21st-annual-pain-therapeutics-virtual-conference-in-may-2021-less-than-two-weeks/ 2021-04-28T11:06:43+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/LC-2-weeks-1200x627-1.jpg http://www.pharmajournalist.com/key-programme-highlights-for-smis-5th-annual-highly-potent-active-pharmaceutical-ingredients-virtual-conference/ 2021-04-29T08:49:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/P-348-LC-2-weeks.jpg http://www.pharmajournalist.com/remestemcel-l-reduces-mortality-in-patients-less-than-65-years-old-with-moderate-severe-covid-19-ards-topline-60-day-results-from-randomized-controlled-trial/ 2021-04-30T11:33:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/mesoblast-logo.png http://www.pharmajournalist.com/pfizer-acquires-amplyx-pharmaceuticals/ 2021-04-30T11:34:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/selumetinib-recommended-for-approval-in-the-eu-by-chmp-as-the-first-medicine-for-paediatric-patients-with-neurofibromatosis-type-1-and-plexiform-neurofibromas/ 2021-04-30T11:37:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/sanofi-to-help-manufacture-moderna-covid-19-vaccine-supporting-global-supply-demands/ 2021-04-30T11:39:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/samsung-biologics-and-tg-therapeutics-expand-collaboration-for-the-large-scale-manufacture-of-ublituximab/ 2021-04-30T11:42:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/pieris-pharmaceuticals-and-boston-pharmaceuticals-enter-into-an-exclusive-worldwide-product-license-for-prs-342-a-4-1bb-gpc3-immuno-oncology-bispecific/ 2021-04-30T11:44:49+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pieris-Pharma-Logo.png http://www.pharmajournalist.com/carisma-therapeutics-establishes-collaboration-with-leading-cell-therapy-expert-to-explore-and-develop-allogeneic-car-macrophages/ 2021-04-30T11:47:41+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Carisma-Therapeutics-Logo.png http://www.pharmajournalist.com/geneseeq-and-astrazeneca-collaborate-to-build-guangzhou-bio-diagnostics-innovation-center/ 2021-04-30T11:49:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/logicbio-therapeutics-announces-strategic-collaboration-and-option-agreement-with-canbridge-pharmaceuticals-leveraging-gene-editing-and-gene-delivery-platforms/ 2021-04-30T11:51:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Logic-Bio-Therapeutics-Logo.png http://www.pharmajournalist.com/essa-pharma-announces-clinical-collaboration-agreement-with-bayer-to-evaluate-the-combination-of-epi-7386-and-darolutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer/ 2021-04-30T11:53:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/sirnaomics-enters-partnership-with-walvax-biotechnology-to-co-develop-its-antiviral-rnai-therapeutic-product-candidate-stp702/ 2021-04-30T11:55:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Sirnaomics_Logo.jpg http://www.pharmajournalist.com/brooklyn-immunotherapeutics-acquires-license-for-mrna-technology-platform-to-develop-genetically-edited-cells-to-treat-multiple-cancers-blood-and-other-disorders/ 2021-04-30T11:58:30+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Brooklyn-Immuno-Therapeutics-Logo.jpg http://www.pharmajournalist.com/mirum-pharmaceuticals-receives-notice-of-allowance-for-methods-of-use-patent-for-maralixibat-in-alagille-syndrome/ 2021-04-30T12:00:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Mirum-Logo.jpg http://www.pharmajournalist.com/amid-humanitarian-crisis-in-india-merck-announces-voluntary-licensing-agreements-with-five-indian-generics-manufacturers-to-accelerate-and-expand-global-access-to-molnupiravir-an-investigational-ora/ 2021-04-30T12:01:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/vetter-and-rentschler-biopharma-further-strengthen-their-strategic-alliance/ 2021-04-30T12:04:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Vetter_Rentschler_strategic_alliance.png http://www.pharmajournalist.com/osteolabs-gmbh-establishes-uk-presence/ 2021-04-30T12:06:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/toxys-and-unilever-enter-agreement-to-further-validate-and-expand-reprotracker-for-animal-free-developmental-toxicity-assessment/ 2021-04-30T12:07:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/eyemate-system-for-remote-glaucoma-management-obtains-fda-breakthrough-device-designation/ 2021-04-30T12:09:37+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Implandata-Eyemate.jpg http://www.pharmajournalist.com/asher-biotherapeutics-contracts-probiogen-to-develop-and-manufacture-their-lead-candidate/ 2021-04-30T12:11:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/genscript-launches-research-grade-lentiviral-vector-packaging-service/ 2021-04-30T12:13:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/GenScript.jpg http://www.pharmajournalist.com/catalent-and-stirling-ultracold-announce-partnership-to-establish-energy-efficient-cold-chain-capabilities-for-biologics-and-emerging-modalities/ 2021-04-30T12:14:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/adma-biologics-receives-fda-approval-for-increased-ivig-production-scale/ 2021-04-30T12:16:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/paths-initiatives-in-developing-next-generation-injectables-discussed-at-pre-filled-syringes-west-coast-2021/ 2021-05-06T08:51:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/novo-nordisks-net-profit-increased-by-6-in-the-first-three-months-of-2021/ 2021-05-07T08:06:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/new-england-journal-of-medicine-publishes-phase-2b-clinical-trial-results-demonstrating-efficacy-of-novavax-covid-19-vaccine-against-the-b-1-351-variant/ 2021-05-07T08:11:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/viiv-healthcare-initiates-rolling-submission-of-new-drug-application-with-us-fda-for-long-acting-cabotegravir-for-prevention-of-hiv/ 2021-05-07T08:13:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/ViiV-Healthcare.png http://www.pharmajournalist.com/hdt-bio-gennova-biopharmaceuticals-announce-first-healthy-volunteers-dosed-in-phase-i-ii-trials-of-unique-covid-19-rna-vaccine-in-india/ 2021-05-07T08:15:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/HDTBio_logo.jpg http://www.pharmajournalist.com/effector-and-quantitative-biosciences-institute-qbi-at-ucsf-receive-5-0-million-from-darpa-to-evaluate-zotatifin-in-covid-19/ 2021-05-07T08:19:12+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/eFFECTOR-Therapeutics-Logo.jpg http://www.pharmajournalist.com/moderna-announces-supply-agreement-with-gavi-for-up-to-500-million-doses-of-covid-19-vaccine-moderna-for-covax-to-help-end-covid-19-pandemic-in-lowest-income-countries/ 2021-05-07T08:21:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/new-data-from-vaxart-oral-covid-19-vaccine-phase-i-study-suggests-broad-cross-reactivity-against-other-coronaviruses/ 2021-05-07T08:23:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Vaxart-Logo.png http://www.pharmajournalist.com/fda-approves-treatment-for-chronic-kidney-disease/ 2021-05-07T08:28:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/thermo-scientific-e-cfeg-enables-accelerated-cryo-em-discovery-with-high-resolution-data/ 2021-05-07T08:51:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/jacobio-announces-fda-approves-ind-application-to-develop-kras-g12c-inhibitor/ 2021-05-07T08:55:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/hoth-therapeutics-announces-development-of-ht-kit-to-treat-multiple-orphan-diseases-including-rare-cancers/ 2021-05-07T09:01:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/Hoth_Logo.png http://www.pharmajournalist.com/enteris-biopharma-completes-expansion-of-manufacturing-facility-and-announces-launch-of-cdmo-business-segment/ 2021-05-07T09:03:00+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/enteris-biopharma-logo.png http://www.pharmajournalist.com/alchemab-to-collaborate-with-astrazeneca-to-use-alchemabs-drug-discovery-platform-for-prostate-cancer-study/ 2021-05-07T09:04:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/vivace-therapeutics-announces-dosing-of-first-cohort-of-patients-with-its-first-in-class-tead-inhibitor/ 2021-05-07T09:11:58+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Vivace-Therapeutics-Logo.jpg http://www.pharmajournalist.com/crownbio-acquires-ocello-b-v-to-expand-its-preclinical-in-vitro-drug-development-service-offerings/ 2021-05-07T09:14:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/esker-therapeutics-launches-to-transform-the-treatment-of-autoimmune-diseases/ 2021-05-07T09:18:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/esker-therapeutics-logo.png http://www.pharmajournalist.com/itm-establishes-subsidiary-in-shanghai-to-accelerate-introduction-of-its-precision-oncology-portfolio-in-china/ 2021-05-07T09:23:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/ITM-Radiopharmaceuticals.jpg http://www.pharmajournalist.com/pfizer-and-biontech-to-provide-covid-19-vaccine-doses-for-olympic-athletes-at-the-2020-tokyo-games/ 2021-05-07T09:28:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/revive-therapeutics-enters-into-research-agreement-with-ucsf-for-bucillamine-as-potential-treatment-for-severe-covid-19/ 2021-05-07T09:31:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Revive-Therapeutics-Logo.jpg http://www.pharmajournalist.com/confirmed-speakers-for-the-upcoming-pre-filled-syringes-san-francisco-conference-2021/ 2021-05-10T12:21:27+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/hear-from-expert-industry-speakers-at-oligonucleotide-therapeutics-and-delivery-2021/ 2021-05-10T14:33:49+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/algernon-pharmaceuticals-announces-ifenprodil-reduced-interleukin-6-in-phase-2b-3-covid-study/ 2021-05-14T07:43:23+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Algernon-Pharma-Logo.png http://www.pharmajournalist.com/lilly-and-mina-therapeutics-announce-sarna-research-collaboration/ 2021-05-14T07:44:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-grants-fast-track-designation-to-cerc-002-for-treatment-of-hospitalized-patients-with-covid-19/ 2021-05-14T07:46:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-authorizes-pfizer-biontech-covid-19-vaccine-for-emergency-use-in-adolescents-in-another-important-action-in-fight-against-pandemic/ 2021-05-14T07:47:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/inovio-announces-positive-data-from-phase-2-segment-of-clinical-trial-evaluating-ino-4800-its-covid-19-dna-vaccine/ 2021-05-14T07:49:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/china-nmpa-approves-parp-inhibitor-pamiparib-for-patients-with-previously-treated-advanced-ovarian-cancer/ 2021-05-14T07:51:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Beigene.jpg http://www.pharmajournalist.com/ontochem-assigns-anixa-covid-19-drug-discovery-project-to-molgenie/ 2021-05-14T07:54:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/02/anixa-biosciences-logo.png http://www.pharmajournalist.com/fore-biotherapeutics-opens-u-s-headquarters-in-philadelphias-biotech-hub/ 2021-05-14T07:57:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Fore-Biotherapeutics.jpg http://www.pharmajournalist.com/pfizer-and-biontech-receive-first-u-s-authorization-for-emergency-use-of-covid-19-vaccine-in-adolescents/ 2021-05-14T07:59:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/x-chem-announces-opendex-dna-encoded-library-screening/ 2021-05-14T08:02:14+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/X-Chem-Logo.png http://www.pharmajournalist.com/feinstein-institutes-clinical-research-to-study-experimental-stroke-drug/ 2021-05-14T08:04:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Temes_PR.jpg https://pharmajournalist.com/wp-content/uploads/2021/05/Temes_PR.jpg http://www.pharmajournalist.com/perkinelmer-expands-cell-biology-leadership-with-agreement-to-acquire-nexcelom-bioscience/ 2021-05-14T08:08:40+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/perkinelmer.png http://www.pharmajournalist.com/inscopix-expands-global-distribution-network-in-eastern-europe/ 2021-05-14T08:11:49+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Inscopix-Logo.jpg http://www.pharmajournalist.com/pregene-and-dr-reddys-announce-license-agreement-for-anti-bcma-car-t-prg1801-in-india/ 2021-05-14T08:13:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/navigo-proteins-and-mdimune-enter-into-a-research-collaboration-on-affilin-mediated-targeting-of-extracellular-vesicles/ 2021-05-14T08:20:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/05/Figure1.png http://www.pharmajournalist.com/novasep-expands-its-hpapi-manufacturing-capacity-in-le-mans-for-innovative-cancer-therapies/ 2021-05-14T09:39:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/NovaSep.jpg http://www.pharmajournalist.com/cordenpharma-colorado-to-double-its-largest-peptide-purification-suite/ 2021-05-14T09:43:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/CordenPharma.png http://www.pharmajournalist.com/hofseth-biocare-announces-global-innovation-partnership-with-catalent-to-develop-delayed-release-formulation-of-omego-fish-oil/ 2021-05-14T09:46:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/emmes-acquires-uk-based-orphan-reach/ 2021-05-14T09:48:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/cambrex-expands-analytical-services-capabilities-at-longmont-colorado-facility/ 2021-05-14T09:50:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/cambrex-logo.png http://www.pharmajournalist.com/registration-is-now-open-for-the-2nd-annual-wearable-injectors-and-connected-devices-conference-2021/ 2021-05-18T09:50:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Wearables.jpg http://www.pharmajournalist.com/seven-key-takeaways-from-joining-aseptic-processing-conference-in-september-2021/ 2021-05-19T07:46:02+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/P-327-Aseptic-Processing-2021-Joint-Sponsors-Banner.jpg http://www.pharmajournalist.com/registration-is-now-open-for-smis-inaugural-medical-wearables-for-biosensors-conference-2021/ 2021-05-20T08:11:46+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Medical-Wearables-for-Biosensors-USA.jpg http://www.pharmajournalist.com/brazilian-health-regulatory-agency-anvisa-authorizes-sorrento-phase-2-pivotal-clinical-trial-of-covi-msc-in-hospitalized-covid-19-patients-with-acute-respiratory-distress-syndrome/ 2021-05-21T12:10:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/pfizer-and-biontech-to-supply-the-european-union-with-up-to-1-8-billion-additional-doses-of-comirnaty/ 2021-05-21T12:14:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/exscientia-announces-multi-target-ai-driven-drug-discovery-collaboration-with-bristol-myers-squibb/ 2021-05-21T12:16:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/veru-enrolls-first-patient-in-phase-3-clinical-trial-of-sabizabulin-veru-111-in-high-risk-hospitalized-covid-19-patients/ 2021-05-21T12:20:14+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Veru-Inc-Logo.png http://www.pharmajournalist.com/sandoz-announces-plans-to-further-strengthen-its-antibiotics-manufacturing-setup-in-europe/ 2021-05-21T12:21:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/agenus-and-bristol-myers-squibb-announce-exclusive-global-license-for-agenus-anti-tigit-bispecific-antibody-program/ 2021-05-21T12:23:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/cytodyn-to-submit-newly-completed-topline-report-of-cd12-trial-results-to-regulatory-agencies-in-multiple-countries-including-india-and-philippines/ 2021-05-21T13:25:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Cytodyn-Logo.jpg http://www.pharmajournalist.com/charles-river-laboratories-to-acquire-vigene-biosciences-to-enhance-gene-therapy-capabilities/ 2021-05-21T13:27:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/astrazeneca-covid-19-vaccine-vaxzevria-authorised-for-emergency-use-in-japan/ 2021-05-21T13:29:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/takeda-announces-approval-of-modernas-covid-19-vaccine-in-japan/ 2021-05-21T13:31:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/mandos-llc-agrees-to-acquire-adrabetadex-from-mallinckrodt-pharmaceuticals/ 2021-05-21T13:32:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/labcorp-to-expand-bioanalytical-services-with-integrated-laboratory-in-singapore/ 2021-05-21T13:34:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Labcorp.jpg http://www.pharmajournalist.com/prestige-biopharma-enters-mou-with-busan-city-for-establishment-of-its-rd-centre-in-busan-south-korea/ 2021-05-21T13:41:35+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/IDC_Blueprint.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/05/IDC_Blueprint.jpg http://www.pharmajournalist.com/affyimmune-therapeutics-aic100-granted-fast-track-designation-for-treating-thyroid-cancer/ 2021-05-21T13:44:12+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Affyimmune-Logo.png http://www.pharmajournalist.com/innocare-announces-approval-of-clinical-trial-of-tyk2-inhibitor-icp-332-in-china/ 2021-05-21T13:46:50+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Innocare-Logo.png http://www.pharmajournalist.com/biomed-x-institute-and-merck-extend-collaboration-to-continue-novel-research-in-oncology-and-autoimmunity/ 2021-05-21T13:48:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/lennham-pharmaceuticals-announces-issuance-of-u-s-patent-covering-deuterated-psilocybin-products/ 2021-05-21T13:50:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/lennham-Pharma-logo.jpg http://www.pharmajournalist.com/gsk-announces-sale-of-stake-in-innoviva-inc/ 2021-05-21T13:52:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/arecor-announces-an-exclusive-formulation-study-collaboration-with-lilly/ 2021-05-21T13:56:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-and-university-of-california-san-francisco-to-open-cell-therapy-cgmp-manufacturing-and-collaboration-center/ 2021-05-21T13:58:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/UCSF_Mission_Bay_Drone.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/05/UCSF_Mission_Bay_Drone.jpg http://www.pharmajournalist.com/gamma-biosciences-acquires-controlling-stake-in-mirus-bio-to-expand-reach-in-gene-therapy-and-next-generation-vaccines/ 2021-05-21T14:01:36+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/gamma-bio-logo.jpeg http://www.pharmajournalist.com/perkinelmer-to-acquire-in-vitro-diagnostics-company-immunodiagnostic-systems-holdings-plc/ 2021-05-21T14:05:19+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/perkinelmer.png http://www.pharmajournalist.com/three-weeks-to-go-until-pre-filled-syringes-west-coast-virtual-conference-2021-registration-closing-soon/ 2021-05-24T13:28:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/digital-healthcare-solutions-connect-engage-measure/ 2021-05-27T07:35:46+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/online-seminar-rectangle-banner-version-2.gif http://www.pharmajournalist.com/wp-content/uploads/2021/05/digital-healthcare-solutions-connect-engage-measure.jpg http://www.pharmajournalist.com/novartis-and-molecular-partners-announce-start-of-empathy-clinical-trial-for-ensovibep-for-the-treatment-of-covid-19/ 2021-05-28T10:20:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/nikang-therapeutics-announces-completion-of-200-million-series-c-financing-to-advance-highly-differentiated-small-molecules-addressing-difficult-to-drug-targets/ 2021-05-28T10:23:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/NK-Logo.jpg http://www.pharmajournalist.com/fda-approves-first-targeted-therapy-for-subset-of-non-small-cell-lung-cancer/ 2021-05-28T10:28:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/tagrisso-approved-in-the-eu-for-the-adjuvant-treatment-of-patients-with-early-stage-egfr-mutated-lung-cancer/ 2021-05-28T10:30:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/astrazeneca-covid-19-vaccine-vaxzevria-authorised-for-emergency-use-in-japan-2/ 2021-05-28T10:31:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ema-issues-positive-scientific-opinion-on-gsk-and-vir-biotechnologys-sotrovimab-for-the-early-treatment-of-covid-19/ 2021-05-28T10:33:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/libtayo-cemiplimab-receives-positive-chmp-opinion-for-the-treatment-in-europe-of-two-advanced-cancers/ 2021-05-28T10:37:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/boehringer-ingelheims-investigational-treatment-for-cognitive-impairment-associated-with-schizophrenia-receives-fda-breakthrough-therapy-designation/ 2021-05-28T10:38:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/dorian-and-hitgen-announce-research-collaboration-focused-on-dna-encoded-library-based-drug-discovery/ 2021-05-28T10:40:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Hitgen-Logo.jpg http://www.pharmajournalist.com/alloy-therapeutics-and-pyxis-oncology-form-kyma-therapeutics-to-develop-novel-immune-modulating-antibodies-for-cancer-and-autoimmune-diseases/ 2021-05-28T10:43:30+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Alloy-Therapeutics.png http://www.pharmajournalist.com/ajinomoto-bio-pharma-services-expands-fill-finish-capacity-with-new-multi-purpose-fill-suite/ 2021-05-28T10:45:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Ajinomoto-Bio-Pharma.jpg http://www.pharmajournalist.com/transgene-and-bioinvent-receive-ind-approval-from-the-u-s-fda-for-bt-001-a-novel-oncolytic-virus-for-the-treatment-of-solid-tumors/ 2021-05-28T10:47:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Transgene-Logo.png http://www.pharmajournalist.com/menarini-silicon-biosystems-launches-new-breakthrough-deparray-plus-image-based-cell-sorter-to-isolate-rare-cells-with-single-cell-precision/ 2021-05-28T10:49:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Menarini-Silicon-Bio-Logo.jpg http://www.pharmajournalist.com/antengene-announces-first-patient-dosed-in-phase-i-ii-trial-of-eltanexor-for-the-treatment-of-myelodysplastic-syndrome/ 2021-05-28T10:52:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Antengene-Logo.jpg http://www.pharmajournalist.com/seelos-therapeutics-receives-european-orphan-drug-designation-for-sls-005-trehalose-in-amyotrophic-lateral-sclerosis-als/ 2021-05-28T10:54:22+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Seelos_Therapeutics_Logo.jpg http://www.pharmajournalist.com/prestige-announces-agreement-to-expand-eye-care-offering-with-acquisition-of-theratears/ 2021-05-28T10:56:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/pieris-pharmaceuticals-announces-respiratory-and-ophthalmology-collaboration-with-genentech/ 2021-05-28T10:58:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pieris-Pharma-Logo.png http://www.pharmajournalist.com/xeris-pharmaceuticals-to-acquire-strongbridge-biopharma-for-267m/ 2021-05-28T11:02:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/key-updates-ahead-of-smis-4th-annual-pharmaceutical-microbiology-west-coast-virtual-conference-in-three-weeks/ 2021-05-28T15:13:32+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/P-322-Pharma-Microbiology-WC-2021-Virtual-1200x627-LC3WK.jpg http://www.pharmajournalist.com/registration-is-open-for-smis-2nd-annual-next-generation-pharmaceutical-cleanroom-2/ 2021-06-01T08:25:17+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/P-330-Pharmaceutical-Cleanroom-2021-300x250-1.jpg http://www.pharmajournalist.com/oligonucleotide-therapeutics-and-delivery-half-day-pre-conference-workshop/ 2021-06-01T15:22:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/an-update-on-combination-product-device-development-discussed-at-pre-filled-syringes-san-francisco-2021/ 2021-06-02T14:28:38+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/morphosys-to-acquire-constellation-pharmaceuticals/ 2021-06-04T10:02:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/moderna-announces-new-drug-substance-production-agreement-with-lonza-in-the-netherlands/ 2021-06-04T10:04:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/nordic-capital-acquires-speciality-pharmaceutical-company-advanz-pharma-in-deal-worth-846-million/ 2021-06-04T10:06:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/amgen-and-kyowa-kirin-to-jointly-develop-and-commercialize-khk4083-a-phase-3-ready-potential-first-in-class-treatment-for-atopic-dermatitis/ 2021-06-04T10:08:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/nrx-pharmaceuticals-seeks-fda-eua-for-covid-19-therapy-zyesami/ 2021-06-04T10:11:56+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/NRX-Pharma-Logo.jpeg http://www.pharmajournalist.com/alkermes-announces-fda-approval-of-lybalvi-for-the-treatment-of-schizophrenia-and-bipolar-i-disorder/ 2021-06-04T10:13:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Alkermes.png http://www.pharmajournalist.com/anheart-therapeutics-and-innovent-biologics-announce-exclusive-license-agreement-for-taletrectinib-in-greater-china/ 2021-06-04T10:17:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/samsung-biologics-to-add-mrna-vaccine-drug-substance-manufacturing-suite-to-expand-portfolio-of-services/ 2021-06-04T10:19:57+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Samsung_Biologics_Manufacturing.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/Samsung_Biologics_Manufacturing.jpg http://www.pharmajournalist.com/nexturn-bio-inc-acquired-a-50-stake-in-rosvivo-therapeutics-inc/ 2021-06-04T10:22:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/point-biopharma-receives-u-s-nuclear-regulatory-commission-materials-license-for-indiana-facility/ 2021-06-04T10:33:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Point-Biopharma-Logo.png http://www.pharmajournalist.com/moderna-announces-agreement-with-thermo-fisher-scientific-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine/ 2021-06-04T10:35:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/primordial-genetics-grants-arcturus-therapeutics-exclusive-license-of-an-rna-polymerase-for-human-and-animal-therapeutics/ 2021-06-04T10:37:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/genscript-biotech-and-ligand-pharmaceuticals-enter-into-global-omniab-licensing-agreement/ 2021-06-04T10:38:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/GenScript.jpg http://www.pharmajournalist.com/biocryst-launches-orladeyo-berotralstat-in-germany/ 2021-06-04T10:40:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocryst-pharma.jpg http://www.pharmajournalist.com/bayer-acquires-noria-and-psma-therapeutics-to-expand-pipeline-in-prostate-cancer/ 2021-06-04T10:46:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/merck-announces-completion-of-organon-co-spinoff/ 2021-06-04T10:48:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/centivax-signs-strategic-collaboration-with-us-nmrc-for-covid-19-antibody/ 2021-06-04T10:49:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/amgen-and-kyowa-kirin-to-jointly-develop-and-commercialize-khk4083-a-phase-3-ready-potential-first-in-class-treatment-for-atopic-dermatitis-2/ 2021-06-04T11:07:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/3-exclusive-speaker-interviews-released-ahead-of-microbiology-west-coast-virtual-conference-in-2-weeks/ 2021-06-07T09:06:54+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/P-322-Pharma-Microbiology-WC-2021-Virtual-1200x627-LC2WK.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/P-322-Pharma-Microbiology-WC-2021-Virtual-1200x627-LC2WK.jpg http://www.pharmajournalist.com/one-week-to-go-until-pre-filled-syringes-west-coast-virtual-conference-2021/ 2021-06-07T09:53:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/registration-is-now-open-for-medical-devices-and-ivd-conference-2021/ 2021-06-09T09:19:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Medical-Devices-and-IVD-conference-2021.jpg http://www.pharmajournalist.com/registration-is-now-open-for-ophthalmic-drugs-conference-2021/ 2021-06-09T09:27:39+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Ophthalmic.jpg http://www.pharmajournalist.com/exclusive-interview-neuropathic-pain-therapeutics-digital-summit/ 2021-06-10T08:59:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Theodore-Price.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/0001-scaled.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/0002-scaled.jpg http://www.pharmajournalist.com/merck-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19/ 2021-06-11T10:45:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/indivior-extends-leadership-position-in-substance-use-disorder-treatment-with-exclusive-agreement-for-leading-asset-targeting-cannabis-related-disorders/ 2021-06-11T10:47:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Indivior-logo.png http://www.pharmajournalist.com/scipher-medicine-and-leading-medical-researchers-in-network-and-data-science-compress-time-to-identify-covid-19-treatments-from-years-to-months/ 2021-06-11T10:50:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Scipher-Medicine-Logo.jpg http://www.pharmajournalist.com/glenmark-releases-interim-data-from-pms-study-on-favipiravir/ 2021-06-11T10:52:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Glenmark-Pharma-Image.jpg http://www.pharmajournalist.com/dermavant-submits-new-drug-application-nda-to-fda-for-tapinarof-cream-for-the-treatment-of-adults-with-plaque-psoriasis/ 2021-06-11T10:54:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/dermavant-logo.jpg http://www.pharmajournalist.com/fda-grants-accelerated-approval-for-aduhelm-as-the-first-and-only-alzheimers-disease-treatment-to-address-a-defining-pathology-of-the-disease/ 2021-06-11T11:31:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/samyang-holdings-and-mcurex-to-co-develop-an-mrna-vaccine-for-covid-19/ 2021-06-11T11:34:17+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/0423_750-2.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/0423_750-2.jpg http://www.pharmajournalist.com/argenx-to-regain-global-rights-to-cusatuzumab/ 2021-06-11T11:35:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/argenx-logo.jpg http://www.pharmajournalist.com/pfizer-and-biontech-to-provide-500-million-doses-of-covid-19-vaccine-to-u-s-government-for-donation-to-poorest-nations/ 2021-06-11T11:37:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/bristol-myers-squibb-and-acceleron-present-first-results-from-phase-2-beyond-study-of-reblozyl-luspatercept-aamt-in-adults-with-non-transfusion-dependentntdbeta-thalassemia/ 2021-06-11T11:39:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/vicore-announces-fda-acceptance-for-pivotal-phase-3-trial-of-c21-in-covid-19/ 2021-06-11T11:41:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/avantor-completes-acquisition-of-ritter-gmbh-and-its-affiliates/ 2021-06-11T11:44:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/arena-pharmaceuticals-announces-orphan-drug-designation-for-etrasimod-for-the-treatment-of-eosinophilic-esophagitis-eoe/ 2021-06-11T11:45:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/ARENA-Pharmaceuticals.png http://www.pharmajournalist.com/know-labs-announces-successful-results-from-pre-clinical-study-validating-bio-rfid-platform-technology/ 2021-06-11T11:48:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/calidi-biotherapeutics-announces-partnership-with-genscript-probio-for-distribution-of-its-supernova-1-technology/ 2021-06-11T11:51:07+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Calidi-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/icosavax-initiates-phase-1-2-trial-of-covid-19-vlp-vaccine-candidate/ 2021-06-11T11:58:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Icosavax-Logo.jpg http://www.pharmajournalist.com/moderna-and-medison-pharma-partner-to-commercialize-modernas-covid-19-vaccine-across-central-eastern-europe-and-israel/ 2021-06-11T11:59:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/biocelerate-continues-to-help-improve-nonclinical-study-operations-through-public-private-partnership-with-the-fda/ 2021-06-11T12:01:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/BioCelerate-Logo.png http://www.pharmajournalist.com/ascletis-received-china-ind-approval-of-its-fxr-agonist-asc42-for-chronic-hepatitis-b-indication/ 2021-06-11T12:03:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ascletis-logo.jpg http://www.pharmajournalist.com/workshop-on-connected-devices-and-digital-health-how-to-navigate-the-u-s-fda-usability-engineering-requirements/ 2021-06-17T09:21:28+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/clinical-advances-of-rnai-therapy-discussed-at-oligonucleotide-therapeutics-and-delivery-conference-2021/ 2021-06-17T09:28:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/connect-with-your-target-audience-in-healthcare/ 2021-06-17T11:36:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/article-2-online-seminar.png http://www.pharmajournalist.com/covid-19-vaccine-astrazeneca-effective-against-delta-indian-variant/ 2021-06-18T10:56:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novartis-receives-fda-breakthrough-therapy-designation-for-investigational-177lu-psma-617-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc/ 2021-06-18T11:00:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/data-published-in-new-england-journal-of-medicine-shows-pfizers-tofacitinib-meets-primary-endpoint-in-brazilian-study-in-patients-hospitalized-with-covid-19-pneumonia/ 2021-06-18T11:01:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-approves-stratagraft-for-the-treatment-of-adults-with-thermal-burns/ 2021-06-18T11:03:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/nrx-pharmaceuticals-announces-positive-data-results-from-zyesami-aviptadil-expanded-access-protocol/ 2021-06-18T11:05:24+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/NRX-Pharma-Logo.jpeg http://www.pharmajournalist.com/hifibio-therapeutics-closes-75-million-series-d-financing-to-accelerate-pipeline-with-two-lead-immuno-oncology-programs-and-validate-its-dis-approach-in-the-clinic/ 2021-06-18T11:07:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/humanigen-initiates-submission-for-lenzilumab-marketing-authorization-in-covid-19-to-the-united-kingdoms-mhra/ 2021-06-18T11:09:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Humanigen_Logo.jpg http://www.pharmajournalist.com/gsk-and-iteos-therapeutics-announce-development-and-commercialisation-collaboration-for-eos-448-an-anti-tigit-monoclonal-antibody-enabling-novel-next-generation-immuno-oncology-combinations/ 2021-06-18T11:11:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/moderna-submits-authorization-application-for-its-covid-19-vaccine-in-adolescents-in-switzerland/ 2021-06-18T11:12:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/fda-takes-steps-to-increase-availability-of-covid-19-vaccine/ 2021-06-18T11:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/kite-and-shoreline-biosciences-enter-into-strategic-partnership-to-develop-novel-allogeneic-cell-therapies/ 2021-06-18T11:31:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Kite-Pharma.jpg http://www.pharmajournalist.com/eisai-and-bristol-myers-squibb-enter-into-global-strategic-collaboration-for-eisais-morab-202-antibody-drug-conjugate/ 2021-06-18T11:32:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/united-therapeutics-announces-fda-acceptance-of-tyvaso-dpi-new-drug-application-for-priority-review/ 2021-06-18T11:34:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/dendreon-pharmaceuticals-invests-in-contract-manufacturing-and-patient-services-for-cell-therapy-partners/ 2021-06-18T11:36:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Dendreon.jpg http://www.pharmajournalist.com/pulmosim-therapeutics-granted-orphan-drug-designation-for-pt001-by-the-fda-to-treat-pulmonary-arterial-hypertension/ 2021-06-18T11:38:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/aucta-pharma-and-oakrum-pharma-announce-launch-of-generic-version-of-jadenur-sprinkle-deferasirox-granules/ 2021-06-18T11:39:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/istari-oncology-announces-fda-granted-fast-track-designation-to-pvsripo-for-the-treatment-of-advanced-melanoma/ 2021-06-18T11:40:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/moderna-and-tabuk-pharmaceuticals-partner-to-commercialize-modernas-covid-19-vaccine-in-saudi-arabia/ 2021-06-18T11:42:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/danaher-to-acquire-aldevron/ 2021-06-18T11:43:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/kbi-biopharma-enters-commercial-manufacturing-agreement-with-am-pharma-to-prepare-for-the-commercial-launch-of-lead-program-in-acute-kidney-disease/ 2021-06-18T12:02:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/kbi-biopharma.jpg http://www.pharmajournalist.com/horizon-therapeutics-plc-announces-purchase-of-manufacturing-facility-to-support-growth-of-on-market-rare-disease-and-pipeline-biologics/ 2021-06-18T12:03:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Horizon-Therapeutics-Logo.jpg http://www.pharmajournalist.com/absci-announces-acquisition-of-target-discovery-company-totient/ 2021-06-18T12:06:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/lumen-bioscience-and-novo-nordisk-enter-into-research-collaboration-to-explore-novel-strategies-to-deliver-oral-biologics-for-cardiometabolic-disease/ 2021-06-18T12:09:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/smis-2nd-annual-pharmaceutical-cleanroom-conference-presents-must-attend-workshops/ 2021-06-21T07:30:37+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/P-330-Pharmaceutical-Cleanroom-2021-1200x627-Workshop-A.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/P-330-Pharmaceutical-Cleanroom-2021-1200x627-Workshop-A.jpg http://www.pharmajournalist.com/engage-with-leading-experts-on-wearable-devices-for-remote-diagnostics-and-patient-monitoring/ 2021-06-22T10:39:13+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Medical-Wearables-for-Biosensors-USA.jpg http://www.pharmajournalist.com/hear-from-industry-experts-at-the-2nd-annual-wearable-injectors-and-connected-devices-conference-2021/ 2021-06-22T10:43:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Wearables.jpg http://www.pharmajournalist.com/fda-accepts-application-for-roches-port-delivery-system-with-ranibizumab-pds-for-treatment-of-neovascular-or-wet-age-related-macular-degeneration-namd/ 2021-06-25T08:49:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/roches-actemra-roactemra-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-covid-19-in-hospitalised-adults-and-children/ 2021-06-25T08:54:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/tiziana-and-fhi-clinical-enter-a-collaboration-agreement-for-a-phase-2-clinical-trial-of-intranasal-foralumab-to-treat-hospitalized-patients-with-severe-covid-19/ 2021-06-25T08:56:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/viiv-healthcare-and-halozyme-enter-global-collaboration-and-license-agreement-for-enhanze-drug-delivery-technology-to-enable-development-of-ultra-long-acting-medicines-for-hiv/ 2021-06-25T08:58:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/ViiV-Healthcare.png http://www.pharmajournalist.com/fujitsu-japan-embarks-on-joint-research-for-covid-19-therapies-using-worlds-fastest-supercomputer-with-researchers-of-research-center-for-advanced-science-and-technology-the-university-of-to/ 2021-06-25T09:00:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/fda-approves-first-oral-blood-thinning-medication-for-children/ 2021-06-25T09:01:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/arrowhead-pharmaceuticals-and-horizon-therapeutics-announce-collaboration-to-develop-rnai-therapeutic-for-uncontrolled-gout/ 2021-06-25T09:03:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/arrowhead-pharma-logo.jpg http://www.pharmajournalist.com/tonix-pharmaceuticals-announces-program-to-develop-tnx-102-sl-for-the-treatment-of-long-covid-syndrome-also-known-as-post-acute-sequelae-of-covid-19-pasc/ 2021-06-25T09:05:07+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/tonix-pharmaceuticals.png http://www.pharmajournalist.com/sanofis-aubagio-obtains-ec-approval-for-paediatric-multiple-sclerosis/ 2021-06-25T09:06:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/biotage-launches-new-automated-platform-for-plasmid-dna-purification/ 2021-06-25T09:09:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Biotage-Logo.jpg http://www.pharmajournalist.com/bioheng-biotech-received-orphan-drug-designation-from-the-u-s-fda-for-the-treatment-of-t-all/ 2021-06-25T09:10:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/qiagen-launches-dedicated-crispr-products-for-rapid-and-simplified-analysis-of-gene-editing-experiments/ 2021-06-25T09:15:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/qiagen-image.jpg http://www.pharmajournalist.com/grace-science-receives-u-s-fda-orphan-drug-designation-for-gs-100-an-aav9-gene-therapy-for-ngly1-deficiency/ 2021-06-25T09:16:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/eurofins-discovery-and-immunoprecise-announce-collaboration-to-expand-their-antibody-discovery-platform/ 2021-06-25T09:18:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Eurofins.png http://www.pharmajournalist.com/amgen-announces-approval-of-aimovig-erenumab-in-japan-for-the-suppression-of-onset-of-migraine-attacks-in-adults/ 2021-06-25T09:20:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/eisai-and-biogen-inc-announce-u-s-fda-grants-breakthrough-therapy-designation-for-lecanemab-ban2401/ 2021-06-25T09:23:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/EISAI.jpg http://www.pharmajournalist.com/european-commission-purchases-additional-150-million-doses-of-modernas-covid-19-vaccine-for-delivery-in-2022/ 2021-06-25T09:32:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/koselugo-approved-in-the-eu-for-children-with-neurofibromatosis-type-1-and-plexiform-neurofibromas/ 2021-06-25T09:34:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/cellpoint-and-lonza-enter-strategic-collaboration-to-deliver-car-t-cells-to-patients-at-point-of-care/ 2021-06-25T11:16:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/chemomab-therapeutics-and-agc-biologics-expand-partnership-to-manufacture-cm-101-for-phase-ii-iii/ 2021-06-25T11:19:32+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Chemomab_Logo.jpg http://www.pharmajournalist.com/frontera-therapeutics-starts-gmp-manufacturing-facility-construction/ 2021-06-25T11:23:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Frontera-therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2021/06/Frontera-therapeutics.jpg http://www.pharmajournalist.com/abcellera-continues-expansion-and-strengthens-future-pandemic-preparedness-with-first-of-its-kind-gmp-manufacturing-facility-for-therapeutic-antibodies-in-canada/ 2021-06-25T11:24:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/abcellera.jpg http://www.pharmajournalist.com/virtual-events-attract-more-new-visitors/ 2021-06-30T10:43:54+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/online-seminar-virtual-events-article-3.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/06/online-seminar-virtual-events-article-3.jpg http://www.pharmajournalist.com/medical-device-regulations-strategies-for-compliance/ 2021-07-01T09:47:15+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Medical-Devices-and-IVD-conference-2021.jpg http://www.pharmajournalist.com/key-topics-for-smis-ophthalmic-drugs-conference-released/ 2021-07-01T10:10:45+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Ophthalmic.jpg http://www.pharmajournalist.com/spotlight-sessions-from-kite-pharma-and-orchard-therapeutics-at-smis-aseptic-processing-conference/ 2021-07-01T14:43:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/P-327-Aseptic-Processing-2021-1200x627-JINGJING-LI.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/07/P-327-Aseptic-Processing-2021-1200x627-Scott-Nicholas.jpg http://www.pharmajournalist.com/sanofi-streamlines-consumer-healthcare-portfolio-in-europe-with-divestiture-of-16-brands-to-stada/ 2021-07-02T09:34:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/gavi-signs-agreement-with-clover-biopharmaceuticals-for-supply-to-covax/ 2021-07-02T09:36:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sanofi-launches-dedicated-vaccines-mrna-center-of-excellence/ 2021-07-02T09:37:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/altimmune-announces-update-on-adcovid-phase-1-clinical-trial/ 2021-07-02T09:47:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/altimmune_logo.png http://www.pharmajournalist.com/redhill-biopharmas-opaganib-inhibits-covid-19-variants-in-preclinical-study/ 2021-07-02T09:51:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo.png http://www.pharmajournalist.com/pieris-pharmaceuticals-receives-orphan-drug-designation-for-cinrebafusp-alfa-for-the-treatment-of-gastric-cancer/ 2021-07-02T09:53:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pieris-Pharma-Logo.png http://www.pharmajournalist.com/jj-reaches-opioid-settlement-agreement-with-new-york-state-consistent-with-terms-of-previously-announced-broader-settlement-agreement-in-principle/ 2021-07-02T09:55:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/mandos-completes-acquisition-of-adrabetadex-from-mallinckrodt-pharmaceuticals/ 2021-07-02T11:30:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/seres-therapeutics-nestle-health-science-announce-ser-109-co-commercialization-license-agreement/ 2021-07-02T11:33:42+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Seres-Therapeutics.jpg http://www.pharmajournalist.com/apellis-and-beam-therapeutics-enter-exclusive-research-collaboration-to-apply-base-editing-to-discover-novel-therapies-for-complement-driven-diseases/ 2021-07-02T11:35:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Apellis-Pharma-Logo.jpg http://www.pharmajournalist.com/bioasis-technologies-inc-and-oxyrane-uk-ltd-enter-into-a-research-collaboration/ 2021-07-02T11:36:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/bioasis-Logo.jpg http://www.pharmajournalist.com/oncusp-therapeutics-commences-operations-to-advance-innovative-oncology-therapies/ 2021-07-02T11:39:13+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/OnCusp-Therapeutics-Logo.png http://www.pharmajournalist.com/prilenia-receives-positive-ema-opinion-on-orphan-drug-designation-for-pridopidine-in-als/ 2021-07-02T11:42:23+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Prilenia-Logo.jpg http://www.pharmajournalist.com/captivate-bio-signs-exclusive-distribution-agreement-with-pl-bioscience-across-north-america/ 2021-07-02T11:43:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/lfb-plasma-acquires-immunotek-bio-center-in-greenacres-and-establishes-flagship-office-in-florida/ 2021-07-02T11:45:51+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/LFB-Plasma-Logo.jpg http://www.pharmajournalist.com/natera-and-bgi-genomics-announce-commercial-launch-of-the-bgi-natera-signatera-assay-in-china/ 2021-07-02T11:48:22+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Natera.png http://www.pharmajournalist.com/philip-morris-international-announces-agreement-to-acquire-fertin-pharma/ 2021-07-02T11:50:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/abbvie-gastroenterology-pipeline-to-be-featured-at-the-16th-congress-of-european-crohns-and-colitis-organisation-ecco/ 2021-07-02T11:52:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/aragen-announces-expansion-of-discovery-research-agreement-with-boehringer-ingelheim/ 2021-07-02T11:53:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/innovent-announces-license-agreement-with-synaffix-in-an-adc-technology-deal/ 2021-07-02T11:54:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/frontage-laboratories-to-acquire-quintara-discovery/ 2021-07-02T11:57:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/850-million-usd-%c2%a590-billion-yen-investment-in-fujifilm-diosynth-biotechnologies-to-add-additional-development-and-manufacturing-capacity/ 2021-07-02T11:58:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/cmic-and-lokavant-partner-to-deploy-clinical-trial-intelligence-platform-powered-by-machine-learning/ 2021-07-02T12:03:14+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Lokavant-Logo.jpg http://www.pharmajournalist.com/askbio-receives-fda-fast-track-designation-for-lion-101-a-novel-investigational-aav-gene-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/ 2021-07-02T12:04:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/AskBio-Logo.jpe http://www.pharmajournalist.com/annex-1-and-its-impact-on-cleanrooms-six-sessions-released-at-smis-pharmaceutical-cleanroom-conference/ 2021-07-06T07:50:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/P-330-Pharmaceutical-Cleanroom-2021-300x250-1.jpg http://www.pharmajournalist.com/hear-from-leading-regulatory-experts-on-updates-on-combination-product-device-development-at-pre-filled-syringes-san-francisco-2021/ 2021-07-07T09:42:30+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/small-activating-rnas-a-novel-therapeutic-class-of-oligonucleotides/ 2021-07-07T09:47:20+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/verge-genomics-announces-three-year-collaboration-with-lilly-to-discover-and-develop-novel-treatments-using-its-ai-driven-all-in-human-platform/ 2021-07-09T17:00:38+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Alice_1.jpg https://pharmajournalist.com/wp-content/uploads/2021/07/Alice_1.jpg http://www.pharmajournalist.com/vaxart-announces-exclusive-worldwide-license-agreement-with-altesa-biosciences-for-its-vapendavir-antiviral-asset/ 2021-07-09T17:02:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Vaxart-Logo.png http://www.pharmajournalist.com/exscientia-accelerates-covid-19-drug-discovery-using-ai/ 2021-07-09T17:03:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/tezepelumab-regulatory-submission-accepted-and-granted-fda-priority-review-in-the-us-for-the-treatment-of-patients-with-asthma/ 2021-07-09T17:05:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/eureka-therapeutics-announces-new-gprc5d-license-agreement-with-sanofi-to-target-multiple-myeloma/ 2021-07-09T17:07:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Eureka-Therapeutics-Logo.png http://www.pharmajournalist.com/algernon-pharmaceuticals-announces-70-enrollment-of-its-ifenprodil-ipf-and-chronic-cough-phase-2-human-study/ 2021-07-09T17:08:57+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Algernon-Pharma-Logo.png http://www.pharmajournalist.com/arctic-vision-joins-forces-with-the-university-of-hong-kong-department-of-ophthalmology-to-discover-and-develop-novel-neuroprotective-therapies-for-ocular-disease/ 2021-07-09T17:11:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/arctic_vision_Logo.jpg http://www.pharmajournalist.com/gsk-and-alector-announce-global-collaboration-in-immuno-neurology-for-two-clinical-stage-first-in-class-monoclonal-antibodies-for-neurodegenerative-diseases/ 2021-07-09T17:13:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/inbrain-neuroelectronics-and-merck-kgaa-darmstadt-germany-collaborate-to-develop-the-next-generation-of-bioelectronic-therapies/ 2021-07-09T17:14:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/toxicology-ind-preclinical-research-services-by-altogen-labs-cro/ 2021-07-09T17:16:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/everest-medicines-announces-that-spero-therapeutics-entered-into-licensing-agreement-with-pfizer-inc-for-spr206-in-ex-u-s-and-ex-asia-territories/ 2021-07-09T17:17:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/standigm-secures-strategic-investment-from-sk-chemicals-for-expanding-its-ai-drug-development-capacity/ 2021-07-09T17:20:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Standigm-Logo.png http://www.pharmajournalist.com/i-mab-expands-emerging-portfolio-of-next-generation-novel-oncology-therapeutics-through-cutting-edge-mrna-and-ai-technology-platforms/ 2021-07-09T17:23:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/I-MAB-Biopharma-Logo.jpg http://www.pharmajournalist.com/sequanta-and-mission-bio-announce-strategic-partnership/ 2021-07-09T17:24:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/united-states-pharmacopeia-acquires-pharmatech-associates-inc-to-expand-services-that-help-ensure-the-quality-of-medicines/ 2021-07-09T17:27:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/USP-Logo.png http://www.pharmajournalist.com/lgm-pharma-launches-standalone-analytical-services-for-drug-developers-and-manufacturers/ 2021-07-09T17:29:30+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/LGM-Pharma-Logo.png http://www.pharmajournalist.com/expanded-gene-therapy-portfolio-supports-more-efficient-adeno-associated-viral-manufacturing/ 2021-07-09T17:31:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/sri-international-enters-drug-discovery-and-research-collaboration-with-sanofi/ 2021-07-09T17:32:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/wearable-injectors-and-connected-devices-conference-will-provide-key-regulatory-updates/ 2021-07-12T10:54:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Wearable-Injectors-and-Connected-Devices-Conference.jpg http://www.pharmajournalist.com/exclusive-interview-released-richard-denk-skan-ag-co-chair-and-speaker-at-smis-aseptic-processing-conference/ 2021-07-14T10:30:28+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/P-327-Aseptic-Processing-2021-1200x627-presentation-Richard-Denk.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/07/P-327-Aseptic-Processing-2021-1200x627-presentation-Richard-Denk.jpg http://www.pharmajournalist.com/hear-key-sessions-on-wearable-devices-for-monitoring-and-remote-diagnostics/ 2021-07-14T10:35:52+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Medical-Wearables-for-Biosensors-USA.jpg http://www.pharmajournalist.com/ocugen-announces-initiation-of-rolling-submission-to-health-canada-for-covaxin/ 2021-07-16T12:09:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Ocugen_Logo.jpg http://www.pharmajournalist.com/kriya-therapeutics-completes-100-million-series-b-financing-to-advance-its-fully-integrated-platform-for-designing-developing-and-manufacturing-transformative-gene-therapies/ 2021-07-16T12:10:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/kintor-pharmaceutical-collaborates-with-fosun-pharma-development-to-commercialise-proxalutamide-for-treatment-of-covid-19-in-india-and-africa/ 2021-07-16T12:12:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/lilly-announces-acquisition-of-protomer-technologies/ 2021-07-16T12:14:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/lilly-and-banner-alzheimers-institute-collaborate-on-planned-phase-3-prevention-trial-of-donanemab/ 2021-07-16T12:17:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/prime-medicine-launches-with-315-million-financing-to-deliver-on-the-promise-of-prime-editing/ 2021-07-16T12:22:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/prime_medicine_logo.jpg http://www.pharmajournalist.com/prothena-and-novo-nordisk-announce-acquisition-agreement-for-prothenas-attr-amyloidosis-programme/ 2021-07-16T12:24:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/nrx-pharmaceuticals-announces-partnership-with-the-israel-institute-for-biological-research-to-complete-development-and-commercialization-of-brilife-covid-vaccine/ 2021-07-16T12:26:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/NRX-Pharma-Logo.jpeg http://www.pharmajournalist.com/labgenius-announces-research-collaboration-with-ablynx-a-sanofi-company/ 2021-07-16T12:28:17+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/LabGenius_8519.jpg http://www.pharmajournalist.com/gentibio-and-forge-biologics-announce-viral-vector-contract-development-and-gmp-manufacturing-partnership/ 2021-07-16T12:44:56+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Forge_Biologics.jpg http://www.pharmajournalist.com/cti-clinical-trial-and-consulting-services-announce-acquisition-of-european-based-dynakin/ 2021-07-16T13:17:20+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/CTI-logo.jpg http://www.pharmajournalist.com/flowmetric-life-sciences-inc-introduces-the-breakthrough-vaxeffect-covid-19-vaccine-immune-response-test/ 2021-07-16T13:19:41+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/VaxEffect_Logo.jpg http://www.pharmajournalist.com/biogen-and-innocare-announce-license-and-collaboration-agreement-for-orelabrutinib-an-innovative-cns-penetrant-btk-inhibitor-for-the-potential-treatment-of-multiple-sclerosis/ 2021-07-16T13:21:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/everest-medicines-announces-strategic-commercial-partnership-with-global-technology-company-tencent/ 2021-07-16T13:22:45+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Everest-Medicines-Logo.jpg http://www.pharmajournalist.com/recipharm-invests-in-fill-finish-capacity/ 2021-07-16T13:25:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-opens-cgmp-plasmid-dna-manufacturing-facility-in-carlsbad-california/ 2021-07-16T13:27:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/medable-opens-new-emea-headquarters-in-dublin-expands-european-presence-to-grow-market-for-decentralized-clinical-trials/ 2021-07-16T13:30:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Medable-Logo.jpg http://www.pharmajournalist.com/medipharm-labs-achieves-major-pharmaceutical-manufacturing-milestone-receives-canadian-gmp-pharmaceutical-drug-establishment-licence/ 2021-07-16T13:32:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/medipharma-labs.jpg http://www.pharmajournalist.com/curia-to-acquire-us-based-lakepharma-expanding-end-to-end-rd-capabilities-and-scale-for-biologics/ 2021-07-16T13:34:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/catalent-signs-agreement-with-jos-pharmaceuticals-to-develop-fast-dissolve-zydis-formulation-for-cannabidiol-as-an-anesthesia-premedication/ 2021-07-16T13:36:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/ionis-enters-exclusive-licensing-agreement-with-bicycle-therapeutics-aimed-at-further-advancing-lica-technology/ 2021-07-16T13:37:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/spi-pharma-launches-ultraburst-the-first-in-class-preformulated-platform-for-flash-orally-dispersible-tablets/ 2021-07-16T13:40:19+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/SPI-Pharma-Logo.png http://www.pharmajournalist.com/keynote-address-from-tuv-sud-and-amgen-at-medical-devices-and-ivd-conference-in-november/ 2021-07-20T08:48:02+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Medical-Devices-and-IVD-conference-2021.jpg http://www.pharmajournalist.com/gain-insight-into-the-latest-treatments-for-glaucoma-and-dry-eye-disease-at-ophthalmic-drugs-conference-2021/ 2021-07-20T08:49:32+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Ophthalmic.jpg http://www.pharmajournalist.com/the-world-clinical-biomarkers-cdx-summit-returns-for-the-11th-year/ 2021-07-21T21:25:40+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/P-Journalist-Banners.png http://www.pharmajournalist.com/wp-content/uploads/2021/07/Speakers.jpg https://pharmajournalist.com/wp-content/uploads/2021/07/Register-Button.png http://www.pharmajournalist.com/arvinas-and-pfizer-announce-global-collaboration-to-develop-and-commercialize-protac-protein-degrader-arv-471/ 2021-07-26T11:14:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-venclexta-in-combination-with-azacitidine-for-the-treatment-of-patients-with-myelodysplastic-syndromes/ 2021-07-26T11:16:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/japan-becomes-first-country-to-approve-ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-covid-19/ 2021-07-26T11:19:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/new-data-for-roches-hemlibra-reinforce-safety-profile-in-people-with-haemophilia-a/ 2021-07-26T11:21:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/imfinzi-approved-in-china-for-the-treatment-of-extensive-stage-small-cell-lung-cancer/ 2021-07-26T11:22:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/acquisition-of-alexion-completed/ 2021-07-26T11:24:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/vaxzevria-is-highly-effective-after-one-dose-against-severe-disease-or-hospitalisation-caused-by-beta-and-delta-variants-of-concern/ 2021-07-26T11:25:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ultomiris-recommended-for-approval-in-the-eu-by-chmp-for-children-and-adolescents-with-paroxysmal-nocturnal-haemoglobinuria/ 2021-07-26T11:26:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/pfizer-and-biontech-announce-collaboration-with-biovac-to-manufacture-and-distribute-covid-19-vaccine-doses-within-africa/ 2021-07-26T11:27:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/takeda-expands-modernas-covid-19-vaccine-supply-in-japan-in-partnership-with-the-japanese-government/ 2021-07-26T11:29:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/imaginab-announces-extension-of-long-standing-partnership-with-boehringer-ingelheim/ 2021-07-26T13:51:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImaginAb-Logo.jpg http://www.pharmajournalist.com/sun-pharma-and-cassiopea-spa-announce-signing-of-license-and-supply-agreements-for-winlevi-clascoterone-cream-1-in-us-and-canada/ 2021-07-26T13:54:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/acorda-therapeutics-announces-agreement-to-commercialize-inbrija-in-spain/ 2021-07-26T14:13:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/pfizer-provides-update-on-u-s-fda-review-of-abrocitinib-and-xeljan-filings/ 2021-07-26T14:14:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/lexeo-therapeutics-expands-cardiac-gene-therapy-pipeline-with-acquisition-of-stelios-therapeutics-and-its-gene-therapy-programs-for-rare-cardiovascular-diseases/ 2021-07-26T14:15:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/rxcelerate-establishes-venture-capital-division-and-makes-first-investment-in-us-metabolic-disease-company/ 2021-07-26T14:17:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/RXCELERATE_VENTURE_CAPITAL_NEW.jpg http://www.pharmajournalist.com/relmada-therapeutics-announces-the-acquisition-of-development-and-commercial-rights-to-novel-psilocybin-and-derivates-program-from-arbormentis-llc/ 2021-07-26T14:35:20+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/relmada_logo_hd_logo.jpg http://www.pharmajournalist.com/bluerock-therapeutics-receives-fda-fast-track-designation-for-da01-in-the-treatment-of-advanced-parkinsons-disease/ 2021-07-26T14:38:35+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/BlueRock-Therapeutics.jpg http://www.pharmajournalist.com/biontech-to-acquire-kites-neoantigen-tcr-cell-therapy-rd-platform-and-manufacturing-facility-in-gaithersburg-md/ 2021-07-26T14:40:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/fda-approves-keytruda-pembrolizumab-plus-lenvima-lenvatinib-combination-for-patients-with-certain-types-of-advanced-endometrial-carcinoma/ 2021-07-26T14:43:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/microbiome-connect-gut-therapeutics-is-back-face-to-face-and-better-than-ever/ 2021-07-27T09:07:53+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/9.8-Pharma-Journalist-Image-Article.png http://www.pharmajournalist.com/wp-content/uploads/2021/07/ks_microbiome-connect-gut_2021_new.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/07/Attendes-Gut-Microbiome.png http://www.pharmajournalist.com/the-evolving-landscape-of-connected-devices-sessions-discussed-at-pre-filled-syringes-san-francisco-2021/ 2021-07-28T09:54:56+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/target-discovery-for-rna-therapeutics-workshop-at-oligonucleotide-therapeutics-conference-2021/ 2021-07-28T09:57:48+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/neuropathic-pain-therapeutics-summit-2021/ 2021-07-30T07:46:44+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Neuropathic-Pain-social-card-Pharma-Journalist.png http://www.pharmajournalist.com/wp-content/uploads/2021/07/Neuropathic-Pain-social-card-Pharma-Journalist.png http://www.pharmajournalist.com/takeda-and-frazier-healthcare-partners-announce-collaboration-to-launch-hillevax-inc-to-develop-clinical-stage-norovirus-vaccine-candidate/ 2021-07-30T16:26:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-broadens-existing-emergency-use-of-lilly-and-incytes-baricitinib-in-patients-hospitalized-with-covid-19-requiring-oxygen/ 2021-07-30T16:28:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-approves-expanded-botox-onabotulinumtoxina-label-to-include-eight-new-muscles-to-treat-adults-with-upper-limb-spasticity/ 2021-07-30T16:30:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/deep-genomics-raises-180m-in-series-c-financing/ 2021-07-30T18:08:48+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/gsk-and-vir-biotechnology-announce-joint-procurement-agreement-with-european-commission-for-covid-19-treatment-sotrovimab/ 2021-07-30T18:10:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/amgen-to-acquire-privately-held-teneobio-for-900-million-in-cash-with-future-contingent-milestone-payments/ 2021-07-30T18:12:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/abbvie-and-calico-announce-second-extension-of-collaboration-focused-on-aging-and-age-related-diseases/ 2021-07-31T09:33:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/dyadic-announces-technology-transfer-and-licensing-agreement-with-south-africas-rubic-consortium-aiming-to-develop-and-commercialize-vaccines-for-distribution-throughout-the-african-continent/ 2021-07-31T09:36:14+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Dyadic-Logo.jpg http://www.pharmajournalist.com/perkinelmer-expands-kras-oncology-drug-discovery-assays-with-new-ready-to-use-alphalisa-kits/ 2021-07-31T09:37:50+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/perkinelmer.png http://www.pharmajournalist.com/shingrix-approved-in-the-us-for-prevention-of-shingles-in-immunocompromised-adults/ 2021-07-31T09:39:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/adagio-therapeutics-partners-with-biocon-biologics-to-bring-potent-and-broadly-neutralizing-covid-19-antibody-treatment-to-patients-in-india-and-select-emerging-markets/ 2021-07-31T09:41:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/melior-pharmaceuticals-announces-execution-of-license-agreement-for-armesocarb-by-adhera-therapeutics/ 2021-07-31T09:47:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/shuttle-pharma-awarded-a-new-patent-for-selective-inhibitors-for-cancer-treatment/ 2021-07-31T09:51:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/bluebird-bio-and-resilience-announce-strategic-alliance-to-develop-next-generation-cell-therapies/ 2021-07-31T09:53:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bluebird-bio-inc.jpg http://www.pharmajournalist.com/cyclo-therapeutics-commences-commercial-scale-manufacturing-for-trappsol-cyclo/ 2021-07-31T09:55:49+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Cyclo-Logo.png http://www.pharmajournalist.com/biogen-and-ionis-report-positive-topline-clinical-data-on-investigational-alzheimers-disease-treatment-at-aaic/ 2021-07-31T10:02:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen.jpg http://www.pharmajournalist.com/nexus-pharmaceuticals-announces-launch-of-potassium-chloride-in-water-for-injection/ 2021-07-31T10:04:27+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/KCL_Launch_Social_Post.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/07/KCL_Launch_Social_Post.jpg http://www.pharmajournalist.com/akston-biosciences-announces-commercial-supply-agreement-of-seppics-adjuvant-to-formulate-akston-shelf-stable-covid-19-vaccine-at-global-scale/ 2021-07-31T10:09:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/lantern-pharma-reacquires-rights-to-phase-2-clinical-trial-in-metastatic-prostate-cancer-and-global-development-commercialization-of-irofulven-lp-100-from-allarity-therapeutics-a-s/ 2021-07-31T10:11:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Lantern-Pharma-Logo.png http://www.pharmajournalist.com/protein-engineering-global-agenda-now-live/ 2021-08-02T09:46:42+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/100.2-Article-small-picture-2-1.png http://www.pharmajournalist.com/wp-content/uploads/2021/08/100.2-article-header-.png http://www.pharmajournalist.com/wp-content/uploads/2021/08/Attendes_Protein.png http://www.pharmajournalist.com/wp-content/uploads/2021/08/100.2-article-header-.png http://www.pharmajournalist.com/the-latest-innovations-in-digital-health-and-on-body-drug-delivery-for-the-pharmaceutical-industry/ 2021-08-03T11:05:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Wearable-Injectors-and-Connected-Devices-Conference.jpg http://www.pharmajournalist.com/how-are-biosensors-playing-a-part-in-the-response-against-covid-19/ 2021-08-03T11:08:04+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Medical-Wearables-for-Biosensors-USA.jpg http://www.pharmajournalist.com/exclusive-interview-with-alexander-stoll-fresenius-kabi-ab-speaker-at-smis-aseptic-processing-conference/ 2021-08-05T10:22:19+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/P-327-Aseptic-Processing-2021-1200x627-Alexander-Stoll-in-person.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/08/P-327-Aseptic-Processing-2021-1200x627-Alexander-Stoll-in-person.jpg http://www.pharmajournalist.com/10-key-reasons-to-join-smis-2nd-annual-next-generation-pharmaceutical-cleanroom-conference/ 2021-08-06T07:56:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/P-330-Pharmaceutical-Cleanroom-20211200x627-banner-in-person.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/08/P-330-Pharmaceutical-Cleanroom-20211200x627-banner-in-person.jpg http://www.pharmajournalist.com/kite-and-appia-bio-announce-collaboration-to-research-and-develop-allogeneic-cell-therapies-for-cancer/ 2021-08-06T15:46:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Kite-Pharma.jpg http://www.pharmajournalist.com/novavax-and-european-commission-finalize-advance-purchase-agreement-for-up-to-200-million-doses-of-covid-19-vaccine/ 2021-08-06T15:49:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/bayer-strengthens-drug-discovery-platform-through-acquisition-of-vividion-therapeutics/ 2021-08-06T15:51:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/nrx-pharmaceuticals-partners-with-mannkind-corporation-to-develop-zyesami-aviptadil-inhaler-for-respiratory-conditions/ 2021-08-06T15:56:29+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/NRx_dry_powder_inhaler.jpg https://pharmajournalist.com/wp-content/uploads/2021/08/NRx_dry_powder_inhaler.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-roches-tecentriq-as-adjuvant-treatment-for-certain-people-with-early-non-small-cell-lung-cancer/ 2021-08-06T15:57:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/lilly-and-incytes-baricitinib-reduced-deaths-among-patients-with-covid-19-receiving-invasive-mechanical-ventilation/ 2021-08-06T16:00:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/ipsen-and-exicure-enter-into-exclusive-collaboration-targeting-rare-neurodegenerative-disorders/ 2021-08-06T16:01:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ipsen-Group-Image.jpg http://www.pharmajournalist.com/fda-approves-nexviazyme-avalglucosidase-alfa-ngpt-an-important-new-treatment-option-for-late-onset-pompe-disease/ 2021-08-06T16:06:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/sanofi-to-acquire-translate-bio-advances-deployment-of-mrna-technology-across-vaccines-and-therapeutics-development/ 2021-08-06T16:08:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/celltrion-healthcare-announces-acceptance-and-priority-review-by-health-canada-of-new-drug-submission-for-its-monoclonal-antibody-treatment-for-covid-19-regdanvimab-ct-p59/ 2021-08-06T16:12:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/astellas-and-minovia-therapeutics-announce-strategic-collaboration-for-novel-mitochondrial-cell-therapy-programs/ 2021-08-06T16:13:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/fda-expands-authorized-use-of-regen-cov-casirivimab-and-imdevimab/ 2021-08-06T16:15:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/amring-pharmaceuticals-inc-announces-the-approval-and-launch-of-generic-isoproterenol-hydrochloride-injection-usp/ 2021-08-06T16:19:14+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Amring-Pharmaceuticals-logo.jpg http://www.pharmajournalist.com/biontech-completes-acquisition-of-kites-neoantigen-tcr-cell-therapy-rd-platform-and-manufacturing-facility-in-gaithersburg-maryland/ 2021-08-06T16:20:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/BioNTech.jpg http://www.pharmajournalist.com/eqrx-and-abcellera-announce-collaboration-to-accelerate-the-advancement-of-new-innovative-medicines/ 2021-08-06T16:22:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/abcellera.jpg http://www.pharmajournalist.com/burning-rock-and-impact-therapeutics-announce-a-global-strategic-partnership-for-companion-diagnostics-development/ 2021-08-06T16:26:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/alkermes-receives-fda-fast-track-designation-for-nemvaleukin-alfa-for-the-treatment-of-mucosal-melanoma/ 2021-08-06T16:27:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Alkermes.png http://www.pharmajournalist.com/dispersol-and-catalent-collaborate-to-establish-kinetisol-technology-manufacturing-hub-for-dispersol-pharmaceutical-pipeline/ 2021-08-06T16:29:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/gc-pharma-and-tottori-university-enter-research-collaboration-and-license-agreement-for-development-of-gm1-gangliosidosis-chaperone-therapy/ 2021-08-06T16:30:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/zeiss-to-host-free-webinar-on-multiscale-and-multi-modal-insights-into-drug-formulation/ 2021-08-06T16:31:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/WP-005-Webinar-Banner-with-.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/08/WP-005-Webinar-Banner-with-.jpg http://www.pharmajournalist.com/akston-biosciences-doses-first-subjects-in-phase-ii-clinical-trial-of-second-generation-protein-subunit-covid-19-vaccine/ 2021-08-06T16:33:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/theres-only-2-weeks-to-go-until-the-neuropathic-pain-therapeutics-summit/ 2021-08-12T07:47:07+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Neuropathic-Pain-attending-companies.png http://www.pharmajournalist.com/wp-content/uploads/2021/08/Neuropathic-Pain-attending-companies.png http://www.pharmajournalist.com/have-you-secured-your-free-pass-to-the-gastrointestinal-cancer-drug-development-summit-yet/ 2021-08-12T07:50:06+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Free-to-attend-Gastrointestinal-GI-Cancer-Drug-Development-Summit.png http://www.pharmajournalist.com/wp-content/uploads/2021/08/Free-to-attend-Gastrointestinal-GI-Cancer-Drug-Development-Summit.png http://www.pharmajournalist.com/wnt-%ce%b2-catenin-targeted-drug-discovery-summit-the-only-conference-that-will-accelerate-your-discovery-development-of-wnt-%ce%b2-catenin-targeted-drugs/ 2021-08-13T11:14:26+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/WNT.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/08/WNT.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/08/WNT-2.jpg http://www.pharmajournalist.com/gentibio-announces-157m-series-a-financing-to-advance-engineered-regulatory-t-cells-as-transformative-therapeutics-with-potential-to-restore-immune-tolerance-and-durably-treat-autoinflammation/ 2021-08-13T11:49:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/i-mab-reports-positive-interim-analysis-from-phase-2-3-study-of-its-gm-csf-antibody-plonmarlimab-tjm2-to-treat-patients-with-severe-covid-19/ 2021-08-13T11:52:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/I-MAB-Biopharma-Logo.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-mercks-supplemental-biologics-license-application-for-keytruda-pembrolizumab/ 2021-08-13T11:54:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/moderna-and-canada-announce-collaboration-to-bring-mrna-manufacturing-to-canada/ 2021-08-13T11:56:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/moderna-announces-new-study-showing-its-covid-19-vaccine-maintains-antibodies-against-variants-of-concern-and-interest-to-6-months/ 2021-08-13T11:57:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/azurrx-biopharma-adds-new-clinical-trial-sites-in-ukraine-for-phase-2-reservoir-clinical-trial-of-niclosamide-for-the-treatment-of-covid-19-gastrointestinal-infections/ 2021-08-13T12:00:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/seagen-and-remegen-announce-exclusive-worldwide-license-and-co-development-agreement-for-disitamab-vedotin/ 2021-08-13T12:03:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/forxiga-approved-in-the-eu-for-the-treatment-of-chronic-kidney-disease-in-patients-with-and-without-type-2-diabetes/ 2021-08-13T12:06:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/inovio-and-advaccine-receive-regulatory-allowance-for-two-heterologous-prime-boost-clinical-trials-in-china-using-ino-4800-inovios-covid-19-dna-vaccine-candidate/ 2021-08-13T12:08:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/epizyme-and-hutchmed-announce-strategic-collaboration-to-develop-and-commercialize-tazverik-tazemetostat-in-greater-china/ 2021-08-13T12:11:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Epizyme-Logo.png http://www.pharmajournalist.com/fulgent-genetics-announces-acquisition-of-csi-laboratories/ 2021-08-13T12:13:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/dalrada-health-and-vivera-pharmaceuticals-announce-new-diagnostic-laboratory-joint-venture/ 2021-08-13T12:15:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/vensica-therapeutics-inks-strategic-partnership-with-merz/ 2021-08-13T12:16:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ceapro-inc-expands-collaboration-with-montreal-heart-institute-mhi-with-new-clinical-study-evaluating-flagship-product-avenanthramide/ 2021-08-13T12:18:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/c4-therapeutics-announces-fda-orphan-drug-designation-for-cft7455-for-the-treatment-of-multiple-myeloma/ 2021-08-13T12:20:53+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/C4-Therapeutics-Logo.jpg http://www.pharmajournalist.com/nimbus-therapeutics-and-schrodinger-extend-longstanding-collaboration-to-discover-novel-therapeutics-for-select-targets/ 2021-08-13T12:25:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/artiva-biotherapeutics-establishes-u-s-research-and-manufacturing-facility-for-nk-cell-therapy-pipeline-development-and-clinical-supply/ 2021-08-13T12:27:52+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Morehouse.jpg https://pharmajournalist.com/wp-content/uploads/2021/08/Morehouse.jpg http://www.pharmajournalist.com/lonza-and-sheba-medical-center-use-cocoon-platform-and-show-successful-clinical-outcomes-in-patients-treated-with-car-t-cell-immunotherapy/ 2021-08-13T12:36:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/nobelpharma-signs-a-license-agreement-for-probiogens-vaccine-manufacturing-platform-age1-cr-pix/ 2021-08-13T12:45:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/precision-nanosystems-sets-time-and-place-to-open-new-genetic-medicine-gmp-biomanufacturing-centre-in-vancouver-bc/ 2021-08-13T12:59:16+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/Finance.jpg http://www.pharmajournalist.com/evotec-biologics-opens-j-pod-1-us-in-redmond-washington/ 2021-08-13T13:00:49+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/evotec.jpg http://www.pharmajournalist.com/aldevrons-collaboration-with-ginkgo-bioworks-yields-manufacturing-breakthrough-for-vaccinia-capping-enzyme-used-for-manufacturing-of-mrna-vaccines/ 2021-08-13T13:02:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/manufacturing-facility-aldevron.jpg http://www.pharmajournalist.com/explore-new-discoveries-in-the-treatment-of-ocular-disease/ 2021-08-17T21:35:53+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/Ophthalmic.jpg http://www.pharmajournalist.com/colgate-palmolive-signs-on-as-headline-partner-for-microbiome-connect-usa/ 2021-08-20T07:42:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/07/Pharma-Journalist-Banner_Microbiome-Oral.png http://www.pharmajournalist.com/wp-content/uploads/2021/08/150.1-Launch-Email-Download-Agenda-5.png http://www.pharmajournalist.com/bristol-myers-squibb-receives-european-commission-approval-for-abecma-idecabtagene-vicleucel/ 2021-08-23T11:11:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/sorrento-announces-its-lead-protein-based-covid-19-vaccine-candidate-dyai-100-elicits-strong-neutralizing-immune-responses-in-vaccinated-animals-against-sars-cov-2-and-multiple-maj/ 2021-08-23T11:13:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/fda-approves-opdivo-nivolumab-for-the-adjuvant-treatment-of-patients-with-high-risk-urothelial-carcinoma/ 2021-08-23T11:22:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/nrx-pharmaceuticals-announces-positive-safety-report-for-zyesami-aviptadil-in-nih-sponsored-activ-3-critical-care-study-in-patients-with-life-threatening-covid-19/ 2021-08-23T11:24:08+00:00 https://pharmajournalist.com/wp-content/uploads/2021/06/NRX-Pharma-Logo.jpeg http://www.pharmajournalist.com/aurinia-acquires-novel-pipeline-assets-targeting-autoimmune-and-kidney-related-diseases/ 2021-08-23T11:26:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aurinia-Pharma-Logo.jpg http://www.pharmajournalist.com/gsk-receives-fda-accelerated-approval-for-jemperli-dostarlimab-gxly-for-adult-patients-with-mismatch-repair-deficient-dmmr-recurrent-or-advanced-solid-tumours/ 2021-08-23T11:28:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/gritstone-and-cepi-announce-agreement-to-advance-second-generation-covid-19-vaccine-program-coral-against-sars-cov-2-variants-of-concern/ 2021-08-23T11:30:01+00:00 https://pharmajournalist.com/wp-content/uploads/2021/01/gritstone-oncology-logo.png http://www.pharmajournalist.com/exelixis-and-invenra-expand-collaboration-to-discover-and-develop-novel-biologics-in-oncology/ 2021-08-23T11:31:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/pfizer-and-biontech-announce-submission-of-initial-data-to-u-s-fda-to-support-booster-dose-of-covid-19-vaccine/ 2021-08-23T11:33:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/hdt-bio-announces-agreement-with-koreas-quratis-to-co-develop-innovative-covid-19-vaccine-in-asia/ 2021-08-23T11:34:29+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/HDTBio_logo.jpg http://www.pharmajournalist.com/innocare-announces-first-subject-dosed-in-clinical-trial-of-icp-332/ 2021-08-23T11:40:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/marrone-bio-innovations-collaborates-with-terramera-to-enhance-product-performance-and-expedite-novel-product-development/ 2021-08-23T11:42:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/virpax-pharmaceuticals-receives-fda-response-and-guidance-on-mms019/ 2021-08-23T11:43:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/nexus-pharmaceuticals-receives-patent-for-emerphed-ready-to-use-ephedrine-sulfate-injection/ 2021-08-23T11:45:00+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/EMERPHED.jpg https://pharmajournalist.com/wp-content/uploads/2021/08/EMERPHED.jpg http://www.pharmajournalist.com/roche-receives-fda-approval-for-first-companion-diagnostic-to-identify-dmmr-solid-tumour-patients-eligible-for-anti-pd-1-immunotherapy/ 2021-08-23T11:46:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/free-exclusive-webinar-on-multiscale-and-multi-modal-insights-into-drug-formulation-join-the-experts/ 2021-08-23T16:12:46+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/WP-005-Webinar-Banner-with-speaker.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/08/WP-005-Webinar-Banner-with-speaker.jpg http://www.pharmajournalist.com/importance-of-understanding-injection-device-needs-in-rare-disease-patients/ 2021-08-23T16:17:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/microrna-therapeutics-targeting-the-pathways-of-human-disease/ 2021-08-23T16:20:37+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/advanced-rwe-applications-in-pharma-summit-is-returning-on-october-26-28-2021-for-its-9th-year/ 2021-08-23T16:29:30+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Pharma-J-Banner-Advertisement-300x250-2.png http://www.pharmajournalist.com/perkinelmer-expands-automated-mycotoxin-detection-kits-portfolio-to-include-all-major-mycotoxins/ 2021-08-25T10:53:03+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/perkinelmer.png http://www.pharmajournalist.com/curia-to-expand-u-s-commercial-manufacturing-capability/ 2021-08-25T10:56:18+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Curia_Rensselaer.jpg https://pharmajournalist.com/wp-content/uploads/2021/08/Curia_Rensselaer.jpg http://www.pharmajournalist.com/alligator-bioscience-announces-immuno-oncology-research-collaboration-and-license-agreement-with-orion-corporation/ 2021-08-25T10:58:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alligator-bioscience-logo.jpg http://www.pharmajournalist.com/nice-recommends-first-treatment-for-rare-blood-disorder/ 2021-08-25T10:59:41+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Blood-platelets-magnified.jpg http://www.pharmajournalist.com/somalogic-and-twist-bioscience-corporation-announce-partnership-to-discover-novel-therapeutic-targets-and-antibodies/ 2021-08-25T11:02:34+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Somalogic-Logo.png http://www.pharmajournalist.com/fda-approves-jardiance-empagliflozin-to-treat-adults-living-with-heart-failure-with-reduced-ejection-fraction-2/ 2021-08-25T11:04:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/gw-pharmaceuticals-zelira-therapeutics-and-roche-gather-for-in-person-cannabinoid-derived-therapeutics-summit/ 2021-08-26T11:08:27+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Cannabinoid-Pharma-J-Banner.png http://www.pharmajournalist.com/pardes-biosciences-initiates-first-in-human-trial-for-pbi-0451-an-oral-antiviral-in-development-to-treat-and-prevent-sars-cov-2-infections/ 2021-08-27T11:14:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/eagle-pharmaceuticals-announces-worldwide-licensing-agreement-with-combioxin-sa-for-phase-2b-3-novel-first-in-class-antitoxin-agent-cal02-in-development-for-combination-use-with-antibiotics-for-the-t/ 2021-08-27T11:16:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/eagle-pharmaceuticals-logo.png http://www.pharmajournalist.com/lilly-and-lycia-therapeutics-enter-into-strategic-collaboration-to-discover-and-develop-novel-lysosomal-targeting-chimera-lytac-degraders/ 2021-08-27T11:17:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/pfizer-and-biontech-initiate-rolling-submission-of-supplemental-biologics-license-application-to-u-s-fda-for-booster-dose-of-comirnaty-in-individuals-16-and-older/ 2021-08-27T11:18:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/european-commission-approves-rinvoq-upadacitinib-as-first-jak-inhibitor-in-the-european-union-for-the-treatment-of-both-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis/ 2021-08-27T11:20:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/shape-therapeutics-enters-into-a-strategic-research-collaboration-with-roche-to-advance-breakthrough-aav-based-rna-editing-technology-for-neuroscience-and-rare-disease-indications/ 2021-08-27T11:22:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/brii-biosciences-announces-positive-data-from-the-phase-3-activ-2-trial-evaluating-combination-brii-196-and-brii-198-in-non-hospitalized-covid-19-patients/ 2021-08-27T11:24:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/pfizer-to-acquire-trillium-therapeutics-inc/ 2021-08-27T11:25:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/pfizer-biontech-covid-19-vaccine-comirnaty-receives-full-u-s-fda-approval-for-individuals-16-years-and-older/ 2021-08-27T11:27:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/genevant-sciences-announces-global-collaboration-and-license-agreement-with-takeda-to-develop-novel-nonviral-gene-therapies-for-up-to-two-rare-liver-diseases/ 2021-08-27T11:29:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-accepts-for-priority-review-bristol-myers-squibbs-application-for-orencia-abatacept-for-the-prevention-of-acute-graft-versus-host-disease-agvhd/ 2021-08-27T11:31:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/fda-clears-thermo-scientific-elia-smdp-s-test-for-use-in-u-s/ 2021-08-27T11:32:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ironwood-pharmaceuticals-announces-fda-approval-of-revised-linzess-linaclotide-label/ 2021-08-27T11:33:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ironwood-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/fsd-pharma-announces-definitive-agreement-to-acquire-lucid-psycheceuticals/ 2021-08-27T11:34:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/12/FSD-Logo.jpg http://www.pharmajournalist.com/provectus-algae-expands-into-new-large-scale-microalgae-biomanufacturing-facility/ 2021-08-27T11:37:49+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/Provectus-Algae-Logo.jpg http://www.pharmajournalist.com/index-pharmaceuticals-receives-fda-clearance-to-start-the-phase-iii-study-conclude-with-cobitolimod/ 2021-08-27T11:39:43+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/indexpharma-logo.jpg http://www.pharmajournalist.com/flexcon-announces-global-launch-of-new-pharmcal-portfolio-for-pharmaceutical-labeling/ 2021-08-27T11:42:33+00:00 https://pharmajournalist.com/wp-content/uploads/2021/08/pharma_group_shot.jpg https://pharmajournalist.com/wp-content/uploads/2021/08/pharma_group_shot.jpg http://www.pharmajournalist.com/bioduro-sundia-acquires-us-based-phase-iii-commercial-drug-product-manufacturing-facility/ 2021-08-27T11:45:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/beigene-announces-acceptance-of-a-supplemental-biologics-license-application-in-china-for-tislelizumab-in-nasopharyngeal-cancer/ 2021-08-27T11:46:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Beigene.jpg http://www.pharmajournalist.com/jw-therapeutics-announces-strategic-partnership-with-meditrust-health/ 2021-08-27T11:48:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/inovio-receives-authorization-to-conduct-phase-3-efficacy-trial-of-its-covid-19-dna-vaccine-candidate-ino-4800/ 2021-08-27T11:51:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/forxiga-approved-in-japan-for-the-treatment-of-chronic-kidney-disease-in-patients-with-and-without-type-2-diabetes/ 2021-08-27T11:53:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/digital-applications-for-on-body-devices-discussed-at-wearable-injectors-and-connected-devices-conference-2021/ 2021-09-01T09:28:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Wearable-Injectors-and-Connected-Devices-Conference.jpg http://www.pharmajournalist.com/on-body-biosensors-a-human-factors-development-approach/ 2021-09-01T09:30:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/05/Medical-Wearables-for-Biosensors-USA.jpg http://www.pharmajournalist.com/smis-aseptic-processing-conference-co-chairs-from-f-ziel-gmbh-and-skan-ag-invite-attendees-to-join-the-virtual-event-in-2-weeks/ 2021-09-07T08:57:59+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/P-327-Aseptic-Processing-2021-1200x627-2WK-Banner-VAO-.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/09/P-327-Aseptic-Processing-2021-1200x627-2WK-Banner-VAO-.jpg http://www.pharmajournalist.com/epygenix-therapeutics-announces-fda-acceptance-of-ind-to-initiate-a-clinical-trial-of-epx-100-to-treat-lennox-gastaut-syndrome/ 2021-09-08T08:49:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/data-from-multiple-studies-show-positive-outcomes-with-gala-therapeutics-rheox-system-for-chronic-bronchitis/ 2021-09-08T08:55:09+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/gala-therapeutics.jpg http://www.pharmajournalist.com/moderna-announces-submission-of-initial-data-to-u-s-fda-for-its-covid-19-vaccine-booster/ 2021-09-08T08:56:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/innovent-and-genfleet-announce-exclusive-global-license-agreement-for-gfh925-kras-g12c-inhibitor/ 2021-09-08T08:57:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/curia-completes-acquisition-of-lakepharma/ 2021-09-08T08:58:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/agilent-and-visiopharm-expand-collaboration-with-worldwide-distribution-agreement/ 2021-09-08T09:00:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ultomiris-approved-in-the-eu-for-children-and-adolescents-with-paroxysmal-nocturnal-haemoglobinuria/ 2021-09-08T09:02:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/astrazeneca-and-european-commission-reach-settlement-agreement-over-vaccine-supply-ending-litigation/ 2021-09-08T09:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novartis-leqvio-inclisiran-analyses-show-effective-and-sustained-ldl-c-reduction-in-two-sub-populations-of-patients-with-ascvd/ 2021-09-08T09:07:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/world-first-agreement-between-novartis-and-the-nhs-enables-broad-and-rapid-access-to-first-in-class-cholesterol-lowering-medicine-leqvio-inclisiran/ 2021-09-08T09:10:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/sorrento-announces-enrollment-of-first-subject-in-brazil-phase-2-study-of-covi-msc-for-treatment-of-covid-19-associated-acute-respiratory-distress-in-icu-patients/ 2021-09-08T09:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/janssen-announces-u-s-fda-approval-of-invega-hafyera/ 2021-09-08T09:16:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/moderna-announces-submission-of-initial-data-to-fda-for-its-covid-19-vaccine-booster/ 2021-09-08T09:18:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/entos-covid-19-dna-vaccine-candidate-approved-for-phase-2-clinical-trial-in-south-africa/ 2021-09-08T09:21:21+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/Entos-Pharmaceuticals.jpg http://www.pharmajournalist.com/teva-and-medincell-announce-fda-acceptance-of-new-drug-application-for-tv-46000-mdc-irm-as-a-treatment-for-patients-with-schizophrenia/ 2021-09-08T09:22:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/senhwas-silmitasertib-covid-19-drug-candidate-receives-positive-interim-review-from-data-monitoring-committee-to-proceed/ 2021-09-08T09:24:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/novartis-sabatolimab-receives-orphan-drug-designation-from-the-european-commission-for-myelodysplastic-syndromes/ 2021-09-08T09:26:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/ucb-announces-briviact-brivaracetam-cv-now-fda-approved-to-treat-partial-onset-seizures-in-pediatric-patients-one-month-of-age-and-older/ 2021-09-08T09:27:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/european-commission-approves-biomarins-voxzogo-vosoritide-for-the-treatment-of-children-with-achondroplasia-from-age-2-until-growth-plates-close/ 2021-09-08T09:30:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Biomarin-Pharma-Logo.jpg http://www.pharmajournalist.com/roche-provides-update-on-tecentriq-us-indication-for-pd-l1-positive-metastatic-triple-negative-breast-cancer/ 2021-09-08T09:32:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-with-conference-chair-nagy-habib-imperial-college-london-for-oligonucleotide-therapeutics-and-delivery-released/ 2021-09-08T09:51:43+00:00 https://pharmajournalist.com/wp-content/uploads/2021/04/oligonucleotide-therapeutics-an.jpeg http://www.pharmajournalist.com/fda-has-declined-humanigens-emergency-use-authorization-eua-request-for-lenzilumab-in-hospitalized-covid-19-patients/ 2021-09-10T15:12:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/sanofi-to-acquire-kadmon-to-further-strengthen-growth-of-transplant-business/ 2021-09-10T15:14:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/sanofi-provides-update-on-phase-3-study-evaluating-rilzabrutinib-for-the-treatment-of-pemphigus/ 2021-09-10T15:15:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/adaptimmune-enters-into-a-strategic-collaboration-with-genentech-to-research-develop-and-commercialize-cancer-targeted-allogeneic-t-cell-therapies/ 2021-09-10T15:17:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Adaptimmune-Therapeutics-logo.png http://www.pharmajournalist.com/takeda-to-manufacture-and-provide-150-million-doses-of-novavax-covid-19-vaccine-candidate-to-the-government-of-japan/ 2021-09-10T15:18:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/australian-biotech-engeneic-develops-world-first-nanocellular-anti-covid-19-vaccine-that-defeats-mutant-viruses-and-stimulates-a-broad-anti-viral-response/ 2021-09-10T15:20:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/ENGENEIC-Logo.png http://www.pharmajournalist.com/neuexcell-therapeutics-and-spark-therapeutics-announce-research-collaboration-agreement-to-develop-a-novel-gene-therapy-for-huntingtons-disease/ 2021-09-10T15:22:47+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/NeuExcell.jpg http://www.pharmajournalist.com/resilience-to-manufacture-mrna-for-modernas-covid-19-vaccine/ 2021-09-10T15:26:25+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/Resilience_Logo.jpg http://www.pharmajournalist.com/virios-therapeutics-granted-new-patent-for-antiviral-inhibitor-combination/ 2021-09-10T15:28:27+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/Virios_Logo.jpg http://www.pharmajournalist.com/telix-to-collaborate-with-kettering-health-on-diagnostic-psma-imaging-targeting-theranostics/ 2021-09-10T15:29:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/inanobio-announces-successful-development-of-novel-nanopore-transistor-prototype-a-step-towards-ultra-fast-dna-sequencing/ 2021-09-10T15:31:41+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/INanoBio-Logo.jpg http://www.pharmajournalist.com/jw-therapeutics-announces-nmpa-approval-of-relmacabtagene-autoleucel-injection-in-china/ 2021-09-10T15:33:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/genequantum-and-brighgene-sign-agreement-for-development-of-antibody-immune-agonist-conjugates/ 2021-09-10T15:35:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/boehringer-ingelheim-and-twist-bioscience-enter-therapeutic-antibody-discovery-collaboration/ 2021-09-10T15:39:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/genequine-selects-exothera-to-support-the-next-stage-of-its-osteoarthritis-gene-therapy-development/ 2021-09-10T15:41:10+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/Exothera_scale_X.jpg http://www.pharmajournalist.com/repligen-and-navigo-gmbh-announce-launch-of-industry-first-protein-a-ligand-for-purification-of-ph-sensitive-antibodies/ 2021-09-10T15:43:06+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/Repligen-Logo.png http://www.pharmajournalist.com/cytiva-triples-single-use-consumables-capacity-in-china/ 2021-09-10T15:45:11+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/image_1.jpg https://pharmajournalist.com/wp-content/uploads/2021/09/image_1.jpg http://www.pharmajournalist.com/frontage-expands-early-drug-discovery-services-through-the-acquisition-of-heyan-biotech/ 2021-09-10T15:46:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/recro-and-biocorrx-expand-development-and-manufacturing-relationship-to-support-bicx104-an-implantable-naltrexone-pellet-for-the-treatment-of-opioid-use-disorder/ 2021-09-10T15:48:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/developments-in-protein-engineering-an-interview-with-panelist-maria-lucas-ceo-zymvol/ 2021-09-14T11:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/Maria-Lucas.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/09/Protein-1.png http://www.pharmajournalist.com/wp-content/uploads/2021/09/Protein-2.png http://www.pharmajournalist.com/wp-content/uploads/2021/09/Protein-3.png http://www.pharmajournalist.com/leading-microbiologists-to-meet-at-smis-10th-annual-pharmaceutical-microbiology-conference-2/ 2021-09-20T09:03:40+00:00 https://pharmajournalist.com/wp-content/uploads/2021/09/P-367-Pharmaceutical-Microbiology.jpg http://www.pharmajournalist.com/wp-content/uploads/2021/09/P-367-Pharmaceutical-Microbiology.jpg http://www.pharmajournalist.com/celltrions-monoclonal-antibody-treatment-for-covid-19-regdanvimab-ct-p59-becomes-the-first-authorized-covid-19-treatment-approved-from-the-korean-ministry-of-food-and-drug-safety-mfds/ 2021-09-20T09:17:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/biocon-biologics-and-serum-institute-life-sciences-announce-strategic-alliance/ 2021-09-20T09:19:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/sanofi-completes-acquisition-of-translate-bio-accelerating-the-application-of-mrna-in-new-vaccines-and-therapeutics/ 2021-09-20T09:22:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/abbvie-and-regenxbio-announce-eye-care-collaboration/ 2021-09-20T09:23:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/everest-medicines-enters-into-comprehensive-agreements-with-providence-therapeutics-to-advance-mrna-vaccines-and-therapies-including-covid-19-vaccines-in-asia-emerging-markets/ 2021-09-20T09:25:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/astrazeneca-to-discover-and-develop-self-amplifying-rna-therapeutics-in-new-collaboration-with-vaxequity/ 2021-09-27T10:24:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novavax-and-serum-institute-of-india-announce-submission-to-world-health-organization-for-emergency-use-listing-of-novavax-covid-19-vaccine/ 2021-09-27T10:28:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/tonix-pharmaceuticals-expands-research-collaboration-to-develop-precision-medicine-techniques-for-covid-19-vaccines-and-therapeutics/ 2021-09-27T10:30:55+00:00 https://pharmajournalist.com/wp-content/uploads/2021/03/tonix-pharmaceuticals.png http://www.pharmajournalist.com/abcellera-and-everest-medicines-announce-multi-target-collaboration-to-advance-new-antibody-therapies/ 2021-09-27T10:47:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/abcellera.jpg http://www.pharmajournalist.com/fda-authorizes-booster-dose-of-pfizer-biontech-covid-19-vaccine-for-certain-populations/ 2021-09-27T10:50:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/boehringer-ingelheim-acquires-abexxa-biologics-to-further-expand-its-research-efforts-in-cancer-immunology-and-novel-immunotherapeutic-approaches/ 2021-09-27T10:52:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/johnson-johnson-announces-real-world-evidence-and-phase-3-data-confirming-strong-and-long-lasting-protection-of-single-shot-covid-19-vaccine-in-the-u-s/ 2021-09-27T10:54:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/fda-approves-repatha-evolocumab-in-pediatric-patients-age-10-and-older-with-heterozygous-familial-hypercholesterolemia/ 2021-09-27T10:56:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/fda-approves-samsung-bioepis-and-biogens-byooviz-sb11-lucentis-biosimilar-ranibizumab-nuna/ 2021-09-27T10:59:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg